Download Curriculum Vitae

CURRICULUM VITAE
QUAN DONG NGUYEN, MD, MSC
Name:
DEMOGRAPHIC AND PERSONAL INFORMATION
CURRENT POSITION
McGaw Memorial Endowed Chair in Ophthalmology
Professor and Chair of Ophthalmology
Director of the Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Address:
Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
3902 Leavenworth Street
Omaha, Nebraska
Phone: (402) 559-4276
Fax: (402) 559-5514
E-mail: [email protected]
EDUCATION AND TRAINING
Education:
1985
1989
1989
1993
Bacc. Phillips Exeter Academy
B.S. Yale University
Molecular Biophysics and Biochemistry
M.Sc. Yale Graduate School of Arts and Sciences
Molecular Biophysics and Biochemistry
M.D. University of Pennsylvania School of Medicine
Post-Doctoral Training:
Internship
1993-1994
Massachusetts General Hospital
Department of Internal Medicine, Harvard Medical School
Residency
1994-1997
Massachusetts Eye and Ear Infirmary
Department of Ophthalmology, Harvard Medical School
Clinical and Research Fellowships
1997-1998
Immunology and Uveitis
Massachusetts Eye and Ear Infirmary, Harvard Medical School
1998-1999
Ocular Immunology
Wilmer Eye Institute, Johns Hopkins University and Hospitals
1999-2001
Medical and Surgical Diseases of the Retina and Vitreous
2
Schepens Eye Research Institute
Massachusetts Eye and Ear Infirmary, Harvard Medical School
PROFESSIONAL EXPERIENCES
1997-1998
1998-1999
1999-2001
2001-2008
2008-2013
2013-
Fellow in Ophthalmology, Harvard Medical School
Assistant in Ophthalmology, Johns Hopkins University School of Medicine
Fellow in Ophthalmology, Harvard Medical School
Post-Doctoral Research Scientist, Schepens Eye Research Institute
Assistant Professor of Ophthalmology
Wilmer Ophthalmological Institute
The Johns Hopkins University School of Medicine
Associate Professor of Ophthalmology
Wilmer Ophthalmological Institute
The Johns Hopkins University School of Medicine
Director
Retinal Imaging Research and Reading Center
Wilmer Ophthalmological Institute
The Johns Hopkins University School of Medicine
Director
Medical Student Education in Ophthalmology
The Johns Hopkins University School of Medicine
McGaw Memorial Endowed Professor of Ophthalmology
Director
Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
RESEARCH ACTIVITIES
EXTRAMURAL FUNDING (Previous, Current, and Pending)
Dates: September 1, 2001 to August 31, 2006
Title: Supplemental Inspired Oxygen for Hypoxia-Related Retinal Diseases
Identification: EY 13552-01
Sponsor: National Eye Institute, National Institutes of Health
Role: Principal Investigator
Percent effort: 90%
Notes: This grant was funded as a K23 Career Development Award.
Dates: September 1, 2003 to August 30, 2005
Title: An Open Label, Pilot (Phase I/II), Dose Escalation Safety and Tolerability
Study of Combretastatin A4 Phosphate in Patients with Neovascular Age-Related
Macular Degeneration
Identification: Young Investigator Award
3
Sponsor: Foundation Fighting Blindness, Inc.
Role: Principal Investigator
Percent effort: 10%
Dates: September 1, 2005 to August 30, 2006
Title: A Pilot, Open-Label, Dose-Escalation Study of the Safety, Tolerability, and
Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects with
Macular Edema Secondary to Diabetes Mellitus
Identification: Innovative Grant Award
Sponsor: Juvenile Diabetes Research Foundation, Inc.
Role: Principal Investigator
Percent effort: 5%
Dates: January 2, 2007 to January 1, 2011
Title: Ranibizumab for Edema of the mAcula in Diabetes: A Phase 2 Multi-Center
Randomized Controlled Study – The READ 2 Study
Identification: Clinical Research Grant Award
Sponsor: Juvenile Diabetes Research Foundation, Inc.
Role: Study Chairman and Chair of the Executive Committee
Percent effort: 45%
Notes: The READ 2 study design is based on the results from the phase 1 study that
was also supported by JDRF through the Innovative Grant Award. There are 14
centers across the United States that participate in the READ 2 study.
Dates: March 1, 2008 to February 28, 2011
Title: Novel Assessment of Early Changes in Diabetic Retinopathy
Identification: 1RO1EY017577-01
Sponsor: National Eye Institute, National Institutes of Health
Role: Principal Investigator
Percent effort: 15% for year 1, 25% for years 2 and 3
Notes: The study is a collaboration among the clinician scientists, physicists, and
engineers at Johns Hopkins University, Catholic University of America, and the
Oregon Health and Science University.
Dates: February 1, 2010 to January 31, 2013
Title: Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 with High
Dose Multi-Center Randomized Controlled Study – The READ 3 Study
Identification: Clinical Research Grant Award
Sponsor: Juvenile Diabetes Research Foundation, Inc.
Role: Study Chairman and Chair of the Executive Committee
Percent effort: 35%
Notes: The READ 3 study design is based on the results from the READ 1 and
READ 2 studies that were also supported by JDRF. There are 15 centers across the
United States that participate in the READ 3 study.
4
Dates: May 1, 2010 to April 30, 2012
Title: Mechanisms of Glucose Toxicity
Identification: 1R24DK084949-01
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health
Role: Principal Investigator for Ophthalmology
Percent effort: 10%
Notes: The study is a collaboration among the clinician scientists and chemists from
five disciplines (Biological Chemistry, Neurology, Nephrology, Cardiology, and
Ophthalmology) at Johns Hopkins University.
Dates: April 1, 2012 to March 31, 2014
Title: A Randomized, Multi-center, Phase II Study of the Safety, Tolerability, and
Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in
Combination with Ranibizumab or Laser Photocoagulation in the Treatment of
Diabetic Macular Edema with Involvement of the FoveAL Center (the iDEAL
Study)
Identification: Clinical Research Grant Award
Sponsor: Juvenile Diabetes Research Foundation, Inc.
Role: Study Chairman and Chair of the Executive Committee
Percent effort: 25%
Notes: The iDEAL Study is a collaborative effort among the Juvenile Diabetes
Research Foundation, iCo Therapeutics, and the Johns Hopkins University to
investigate the role of a C-raf kinase inhibitor in diabetic macular edema. The
Study is being conducted across 25 centers in the United States.
PUBLICATIONS
Original Peer-Reviewed Research Articles
1.
Raha D, Nguyen QD, Garen A. “Molecular and Developmental Analyses of the
Protein Encoded by the Drosophila Gene ectodermal.” Developmental Genetics.
1990;11: 310-317.
2.
Nguyen QD, Foster CS. “Ciliary Body Melanoma Masquerading as Chronic
Uveitis.” Ocular Immunology and Inflammation. 1998; 6: 253-256.
3.
Nguyen QD, Kempen JH, Bolton SG, Dunn JP, and Jabs DA. “Immune Recovery
Uveitis in Patients with AIDS and Cytomegalovirus Retinitis Following Highly
Active Antiretroviral Therapy.” American Journal of Ophthalmology. 2000; 129:
634-639.
5
4.
Nguyen QD, Uy HS, Akpek EK, Harper SL, Zacks DN, Foster CS.
“Choroidopathy of Systemic Lupus Erythematosus.” Lupus. 2000; 9: 288-298.
5.
Nguyen QD, Humphrey RL, Dunn JP, Humayun MS. “Elevated Vitreous
Concentration of Monoclonal Immunoglobulin Presenting as Schlieren in Juvenile
Rheumatoid Arthritis-Associated Uveitis.” Archives of Ophthalmology. 2001; 119:
293-296.
6.
Uy HS, Nguyen QD, Arbour J, Gravel M, D’Amico DJ, Jakobiec FA, Foster CS.
“Sclerosing Pseudotumor of the Eye.” Archives of Ophthalmology. 2001; 119: 603607.
7.
Letko E, Stechschulte SU, Kenyon KR, Sadeq N, Romero TR, Samson CM,
Nguyen QD, Harper SL, Primack JD, Azar DT, Gruterich M, Dohlman CH,
Baltatzis S, Foster CS. “Amniotic Membrane Inlay and Overlay Grafting for
Corneal Epithelial Defects and Stromal Ulcers.” Archives of Ophthalmology.
2001; 119: 659-663.
8.
Nguyen QD, Lashkari K, Hirose T, Pruett RC, McMeel JW, Schepens CL.
“Erosion and Intrusion of Silicone Scleral Buckle: Presentation and Management.”
Retina. 2001; 21: 214-220.
9.
Nguyen QD, Uy HS, Merchant A, Medina CA, Baltatzis, Zhao T, Zhao ZS, Cantor
H, Foster CS. “Effect of Fas and Fas-Ligand Deficiency in Resistance of C57BL/6
Mice to HSV-1 Keratitis and Chorioretinitis.” Investigative Ophthalmology and
Visual Science. 2001; 42: 2505-2509.
10.
Harper SL, Letko E, Samson CM, Zafirakis P, Sangwan V, Nguyen QD, Uy H,
Baltatzis S, Foster CS. “Wegener’s Granulomatosis: the Relationship between
Ocular and Systemic Disease.” Journal of Rheumatology. 2001; 28: 1025-1032.
11.
Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller, JA, Handa JT,
Nguyen QD, Sung JU. “Clinical Protocol. An Open-Label, Phase I, Single
Administration, Dose-Escalation Study of ADGVPEDF.11D (ADPEDF) in
Neovascular Age-Related Macular Degeneration (AMD).” Human Gene Therapy.
2001; 12: 2029-2032.
12.
Nguyen QD, Kruger EF, Kim AJ, Lashkari MH, Lashkari K. “Combat Eye
Trauma: Intraocular Foreign Body during the Iran-Iraq War 1980-1988.”
International Ophthalmology Clinics. 2002; 42: 167-177.
13.
Papaliodis GN, Nguyen QD, Samson CM, Foster CS. “Intraocular Lens Tolerance
in Surgery for Cataracta Complicata: Assessment of Four Implant Materials.”
Seminars in Ophthalmology. 2002; 17: 120-123.
6
14.
Nguyen QD, Do DV, Feke GT, Demirjian ZN, Lashkari K. “Heparin-Induced
Antiheparin-Platelet Antibody Associated with Retinal Venous Thrombosis.”
Ophthalmology. 2003; 100: 600-603.
15.
EyeTech Study Group. “Anti-Vascular Endothelial Growth Factor Therapy for
Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular
Degeneration: Phase II Study Results.” Ophthalmology. 2003; 110: 879-881. (Dr.
Nguyen was an investigator in the EyeTech Study Group).
16.
Kramer HJ, Nguyen QD, Curhan G, Hsu CY. “Renal Insufficiency in the Absence
of Albuminuria and Retinopathy Among Adults with Type 2 Diabetes Mellitus.”
JAMA. 2003; 289: 3273-3277.
17.
Early Treatment for Retinopathy of Prematurity Cooperative Group. “Revised
Indications for the Treatment of Retinopathy of Prematurity: Results of the Early
Treatment for Retinopathy of Prematurity Randomized Trial.” Archives of
Ophthalmology. 2003; 121: 1684-1694. (Dr. Nguyen was an investigator in the
ET-ROP Cooperative Group).
18.
Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA.
“Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study.”
Investigative Ophthalmology and Visual Science. 2004; 45: 617-624.
19.
Campochiaro PA and the C99-PKC412-003 Study Group. “Reduction of Diabetic
Macular Edema by Oral Administration of the Kinase Inhibitor PKC 412.”
Investigative Ophthalmology and Visual Science. 2004; 45: 922-931. (Dr. Nguyen
was a member of the PKC412 Study Group).
20.
Do DV, Shah SM, Sung JU, Haller JA, Nguyen QD. Persistent Diabetic Macular
Edema is Associated with Elevated Hemoglobin A1C. American Journal of
Ophthalmology. 2005;139: 620-623.
21.
Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
Mycophenolate Mofetil Therapy for Inflammatory Eye Disease. Ophthalmology.
2005; 112: 1472-1477.
22.
The Standardization of Uveitis Nomenclature (SUN) Working Group [Dr. Nguyen
is a member of the SUN Working Group]. Standardization of Uveitis
Nomenclature for Reporting Clinical Data. Results of the First International
Workshop. American Journal of Ophthalmology. 2005; 140: 509-516.
23.
Campochiaro PA, Nguyen QD, Shah SM, Klein ML, Holz E, Frank RN, Saperstein
DA, Gupta A, Stout JT, Macko J, DiBartolomeo R, Wei LL. Adenoviral VectorDelivered Pigment Epithelium-Derived Factor for Neovascular Age-Related
Macular Degeneration: Results of a Phase 1 Clinical Trial. Human Gene Therapy.
2006; 17: 167-176.
7
24.
Do DV, Nguyen QD, Bressler NM, Schachat AP, Solomon SD, Melia M, Bressler
SB. Hemoglobin A1c Awareness among Patients Receiving Eye Care at a Tertiary
Ophthalmic Center. American Journal of Ophthalmology. 2006; 141: 951-953.
25.
Nguyen QD, Shah SM, Hafiz G, Quinlan E, Sung JU, Chu K, Cedarbaum J,
Campochiaro PA, and the CLEAR Investigators. A Phase 1 Trial of Intravenously
Administered VEGF Trap for Treatment in Patients with Choroidal
Neovascularization due to Age-Related Macular Degeneration. Ophthalmology.
2006; 113: 1522-1530.
26.
Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung JU, ZimmerGaller I, Do DV, Campochiaro PA. Vascular Endothelial Growth Factor is a
Critical Stimulus for Diabetic Macular Edema. American Journal of
Ophthalmology. 2006; 142: 961-969.
27.
Shah SM, Tatlipinar S, Quinlan E, Sung JU, Tabandeh H, Nguyen QD, ZimmerGaller I, Symmons RCA, Campochiaro PA. Dynamic and Quantitative Analysis of
Choroidal Neovascularization by Fluorescein Angiography. Investigative
Ophthalmology and Visual Science. 2006; 47: 5460-5468.
28.
Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR,
Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL,
Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI,
Miskala PH. Relationship between Optical Coherence Tomography-Measured
Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema.
Ophthalmology. 2007; 114: 525-536.
29.
Tatlipinar S, Shah SM, Campochiaro PA, Nguyen QD. Intraobserver Repeatability
of Automated versus Adjusted Optical Coherence Tomography Measurements in
Patients with Neovascular Age-Related Macular Degeneration. Ophthalmologica.
2007; 221: 227-232.
30.
Gerstenblith A, Thorne JE, Sobrin L, Do DV, Shah SM, Jabs DA, Foster CS,
Nguyen QD. Punctate Inner Choroidopathy: Survey Analysis of 77 Persons.
Ophthalmology. 2007; 114: 1201-1204.
31.
Do DV, Cho M, Nguyen QD, Shah SM, Handa JT, Campochiaro PA, ZimmerGaller I, Sung JU, Haller JA. Impact of Optical Coherence Tomography on
Surgical Decision Making for Epiretinal Membranes and Vitreomacular Traction.
Transaction of the American Ophthalmological Society. 2007;104: 161-6.
32.
Nguyen QD, Shah SM, Hafiz G, Do DV, Haller JA, Pili R, Zimmer-Galler I, Janjua
K, Symons RCA, Campochiaro PA. Intravenous Bevacizumab Causes Regression
of Choroidal Neovascularization Secondary to Diseases other than Age-Related
Macular Degeneration. American Journal of Ophthalmology 2008; 145(2): 257-
8
266.
33.
Campochiaro PA, Hafiz G, Shah SM, Nguyen QD, Ying H, Do DV, Quinlan
E, Zimmer-Galler I, Haller JA, Solomon SD, Sung JU, Hadi Y, Janjua KA, Jawed
N, Choy DF, Arron JR. Ranibizumab for Macular Edema due to Retinal Vein
Occlusions: Implication of VEGF as a Critical Stimulator. Molecular Therapy
2008; 16(4):791-799.
34.
Ramella-Roman J, Mathews SA, Kandimalla H, Nabili A, Duncan DD, D'Anna
SA, Shah SM, Nguyen QD. Measurement of Oxygen Saturation in the Retina with
a Spectroscopic Sensitive Multi Aperture Camera. Optics Express 2008; 16 (9):
6170-6182.
35.
Chen JK, Khurana RN, Nguyen QD, Do DV. The Incidence of Endophthalmitis
following Transconjunctival Sutureless 25- versus 20-gauge Vitrectomy. Eye 2008;
June 6.
36.
Lim LL, Scarborough JD, Thorne JE, Graham E, Kempen JH, Mackensen F,
Nguyen QD, Prabriputaloong T, Read RW, Suhler EB, Schwartz JM, Smith JR.
Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;
Feb;147:332-338.
37.
Do DV, Nguyen QD, Shah SM, Browning DJ, Haller JA, Chu K, Yang K,
Cedarbaum JM, Vitti RL, Ingerman A, Campochiaro PA. An Exploratory Study of
the Safety, Tolerability and Bioactivity of a Single Intravitreal Injection of Vascular
Endothelial Growth Factor Trap-Eye in Patients with Diabetic Macular Oedema.
Br J Ophthalmol. 2009; Feb;93:144-9.
38.
Paganelli F, Cardillo JA, Melo LA, Lucena DR, Silva AA, Oliveira AG, HoflingLima A, Nguyen QD, Kuppermann B, Belfort R, Costa R, Lavinsky D, Skaf M,
Lima-Filho AA. A Single Intraoperative Sub-Tenons Capsule Injection of
Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract
Surgery. Invest Ophthalmol Vis Sci. 2009 Feb 21.
39.
Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P,
Campochiaro PA; READ-2 Study Group. Primary End Point (Six Months) Results
of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study.
Ophthalmology. 2009; 116: 2175-81.
40.
Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R,
Arron JR. Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples.
Ophthalmology. 2009; 116: 2158-64.
41.
Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser
P, Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL,
9
Berliner AJ, Cedarbaum JM, Campochiaro PA. A Phase I Study of Intravitreal
Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular AgeRelated Macular Degeneration. Ophthalmology. 2009; 116: 2141-48.
42.
The SCORE Study Research Group. A Randomized Trail Comparing the Efficacy
and Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss
Associated with Macular Edema Secondary to Central Retinal Vein Occlusion.
Archives of Ophthalmology. 2009; 127: 1101-1114. [Dr. Nguyen was a member
of the SCORE Study Research Group and was the Principal Investigator for the
Wilmer Eye Institute.]
43.
The SCORE Study Research Group. A Randomized Trail Comparing the Efficacy
and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss
Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion.
Archives of Ophthalmology. 2009; 127: 1115-1128. [Dr. Nguyen was a member
of the SCORE Study Research Group and was the Principal Investigator for the
Wilmer Eye Institute.]
44.
Campochiaro PA, Hafiz G, Channa R, Shah SM, Nguyen QD, Ying H, Do DV,
Zimmer-Galler I, Solomon DS, Sung JU, Syed B. Antagonism of Vascular
Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions:
Two-Year Outcomes. Ophthalmology. 2010.
45.
Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G,
Lockridge JA, Guerciolina R, Nguyen QD for the Sirna-027 Study Investigators.
RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by
Sira-027. American Journal of Ophthalmology. 2010;150: 33-39.
46.
Campochiaro PA, Hafiz G, Shah SM, Bloom S, Brown DM, Busquets M, Ciulla T,
Friner L, Sabates N, Billman K, Kapik B, Green K, Kane F, Nguyen QD, and the
FAMOUS Study Group. Sustained Ocular Delivery of Fluocinolone Acetonide by
an Intravitreal Insert. Ophthalmology. 2010; 117: 1393-9. [Dr. Nguyen was a
member of the FAMOUS Study Group.]
47.
Campochiaro PA, Shah SM, Hafiz G, Heier JS, Zimmer-Galler I, Channa R,
Nguyen QD, Syed B, Do DV, Lu L, Monk J, Cooke JP, Kengatharan MK, Hsu HH.
Topical Mecamylamine for Diabetic Macular Edema. American Journal of
Ophthalmology. 2010: 149: 839-51.
48.
Shah SM, Nguyen QD, Mir HS, Polito A, Hafiz G, Tatlipinar S, Do DV, Vitale S,
Haller J. A Randomized, Double-Masked Controlled Clinical Trial of Sandostatin
Long-Acting Release Depot in Patients with Postsurgical Cystoid Macular Edema.
Retina. 2010; 30:160-6.
10
49.
Kashani AH, Zimmer-Galler I, Shah SM, Dustin L, Do DV, Eliott D, Haller J,
Nguyen QD. Retinal Thickness Analysis by Race, Gender, and Age using Stratus
OCT. American Journal of Ophthalmology. 2010; 149; 496-502.
50.
Cardillo JA, Paganelli F, Melo LA Jr, Silva AA Jr, Pizzolitto AC, Nguyen QD
Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group.
Subconjunctival Delivery of Antibiotics in a Controlled-Release System: A Novel
Anti-Infective Prophylaxis Approach for Cataract Surgery. Archives of
Ophthalmology. 2010; 128: 81-7. [Dr. Nguyen is a member of the Brazilian
Ocular Pharmacology and Pharmaceutical Technology Research Group.]
51.
Jabs DA, Martin BK, Forman MS, Cytomegalovirus Retinitis and Viral Resistance
Research Group. Mortality Associated with Resistant Cytomegalovirus Among
Patients with Cytomegalovirus Retinitis and AIDS. Ophthalmology. 2010; 128:
128-132. [Dr. Nguyen was a member of the Cytomegalovirus Retinitis and Viral
Resistance Research Group.]
Wang J, Ibrahim M, Turkcuoglu P, Hatef E, Khwaja A, Channa R, Do DV, Nguyen
QD. Intercellular Adhesion Molecule Inhibitors as Potential Therapy for
Refractory Uveitic Macular Edema. Ocular Immunology and Inflammation. 2010.
52.
53.
54.
Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O,
Bodaghi B. A Cross-Sectional Study of the Current Treatment Patterns in
Noninfectious Uveitis among Specialists in the United States. Ophthalmology.
2010.
Paganellli F, Cardillo JA, Dare AR, Melo LA Jr, Lucena DR, Silva AA Jr, Oliveira
AG, Pizzlitto AC, Lavinsky D, Skaf M, Souza-Filho AA, Hofling-Lima AL,
Nguyen QD, Kupperman BD, Herrero-Vanrell R, Belfort R Jr, Brazilian Ocular
Pharmacology and Pharmaceutical Technology Research Group. Controlled
Transscleral Drug Delivery Formulations to the Eye: Establishing New Concepts
and Paradigms in Ocular Anti-inflammatory Therapeutics and Antibacterial
Prophylaxis. Expert Opinion Drug Delivery, 2010; 7: 955-65. (Dr. Nguyen is a
member of the Brazilian Ocular Pharmacology and Pharmaceutical Technology
Research Group).
55.
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier
JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A,
Ciulla TA, Pollack JS, Lim JI, Eliot D, Campochiaro PA; READ-2 Study Group.
Two-Year Outcomes of the Ranibizumab for Edema of the Macula in Diabetes
(READ-2) Study. Ophthalmology. 2010; 117: 2146-2151.
56.
Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos
Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ;
Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS,
11
Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di
Padova F. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on
Psoriasis, Rheumatoid Arthritis, and Uveitis. Science and Translational Medicine.
2010; 2:52ra72.
57.
De Stefano VS, Abechain JJ, De Almeida LF, Verginassi DM, Rodrigues EB,
Freymuller E, Maia M, Magalhaes O Jr, Nguyen QD, Farah ME. Experimental
Investigation of Needles, Syringes, and Techniques for Intravitreal Injections.
Clinical and Experimental Ophthalmology. 2010.
58.
Duncan DD, Lemaillet P, Ibrahim M, Nguyen QD, Hiller M, Ramella-Roman J.
Absolute Blood Velocity Measured with a Modified Fundus Camera. Journal of
Biomedical Optics. 2010; 15: 056014.
59.
Saidha S, Syc SB, Ibrahim M, Eckstein C, Warner CV, Farrell SK, Oakley JD,
Durbin MK, Meyer SABalcer LJ, Frohman EM, Newsome S, Ratchford JN,
Nguyen QD, Calabresi PA. Primary Retinal Pathology in Multiple Sclerosis as
Detected by Optical Coherence Tomography. Brain. 2011; 134: 518-533.
60.
Hatef E, Turkcuoglu P, Ibrahim M, Sepah Y, Shulman M, Heo J, Lee JH, Channa
R, Khwaja A, Rentiya Z, Shah SM, Do DV, Nguyen QD. Importance of Proper
Diagnosis for Management: Multifocal Choroiditis Mimicking Ocular
Histoplasmosis Syndrome. Journal of Ophthalmic Inflammation and Infection.
2011; 1: 55-63.
61.
Brown DM, Heier JS, Ciulla T, Benz M, Abraham P, Yancopoulos G, Stahl N,
Ingerman A, Vitti R, Berliner AJ, Yang K, Nguyen QD. Primary Endpoint Results
of a Phase 2 Study of Vascular Endothelial Growth Factor (VEGF) Trap-Eye in
Wet Age-Related Macular Degeneration. Ophthalmology. 2011; 118: 1089-1097..
62.
Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, Stahl N,
Ingerman A, Vitti R, Berliner AJ, Yang K, Brown DM. One-Year Results of
CLEAR-IT 2, a Phase2 Study Evaluating VEGF Trap-Eye Dosed on an As-Needed
Schedule Following 12-Week Fixed Dosing. Ophthalmology. 2011; 118:10981106.
63.
Hatef E, Colantuoni E, Wang J, Ibrahim M, Shulman M, Adhi F, Sepah YJ, Channa
R, Khwaja A, Nguyen QD, Do DV. The Relationship between Macular sensitivity
and Retinal Thickness in Eyes with Diabetic Macular Edema. American Journal of
Ophthalmology. 2011; 152: 400-405.
64.
Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R,
Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate
Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate
Inner Choroidopathy. Ocular Immunology and Inflammation. 2011; 19: 286-92.
12
65.
Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G,
Grunwald J, Gugleta K, Harris A, Hudson C, Januleviciene I, Kagemann L, Kergoat
H, Lovasik JV, Lanzl I, Martinez A, Nguyen QD, Plange N, Reitsamer HA, Sehi
M, Siesky B, Zeitz O, Orgül S, Schmetterer L. Use of Colour Doppler Imaging in
Ocular Blood Flow Research. Acta Ophthalmologica. 2011; 23: 5557-5562.
66.
Ibrahim MA, Sepah YJ, Symons RC, Channa R, Hatef E, Khwaja A, Bittencourt M,
Heo J, Do DV, Nguyen QD. Spectral- and Time-Domain Optical Coherence
Tomography Measurements of Macular Thickness in Normal Eyes and Eyes with
Diabetic Macular Edema. Eye (Lond). 2012; 26: 454-462.
67.
Sepah YJ, Hatef E, Colantuoni E, Wang J, Shulman M, Adhi FI, Akhtar A, Ibrahim
M, Khwaja A, Channa R, Sophie R, Bittencourt M, Heo J, Do DV, Nguyen QD.
Macular sensitivity and Fixation Patterns in Normal Eyes and Eyes with Uveitis
with and without Macular Edema. Journal of Ophthalmic Inflammation and
Infection. 2012;;2:65-73.
68.
Channa R, Ibrahim M, Sepah Y, Turkcuoglu P, Lee JH, Khwaja A, Hatef E,
Bittencourt M, Heo J, Do DV, Nguyen QD. Characterization of Macular Lesions
in Punctate Inner Choroidopathy with Spectral Domain Optical Coherence
Tomography. Journal of Ophthalmic Inflammation and Infection. 2012; [Epub]
69.
Sheppard JD Jr, Nguyen QD, Usner DW, Comstock TL. Post-cataract Outcomes in
Patients with Non-infectious Posterior Uveitis Treated with the Fluocinolone
Acetonide Intravitreal Implant. Clinical Ophthalmology. 2012;6:79-85.
70.
Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy
J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS and the RISE and RIDE Research
Group. Ranibizumab for Diabetic Macular Edema – Results from Two Phase III
Randomized Trials: RISE and RIDE. Ophthalmology. 2012;119(4):789-801.
71.
Liu TY, Ibrahim M, Bittencourt M, Sepah YJ, Do DV, Nguyen QD. Retinal
Optical Coherence Tomography Manifestations of Intraocular Lymphoma. .
Journal of Ophthalmic Inflammation and Infection. 2012; [Epub]
72.
Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner
AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS; DA VINCI
Study Group*. One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in
Eyes with Diabetic Macular Edema. Ophthalmology. 2012; 119:1658-65.
73.
Paskowitz DM, Nguyen QD, Gehlbach P, Handa JT, Solomon S, Stark W, Shaikh
O, Semba C, Gadek TR, Do DV. Safety, Tolerability, and Bioavailability of
Topical SAR 1118, a Novel Antagonist of Lymphocyte Function-Associated
Antigen-1: A Phase 1b Study. Eye (Lond). 2012; 26: 944-949.
74.
Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, ChiBurris K, Yan E, Paggiarino DA, Rosenblatt I, Khan A, Aitchison R, Erlich SS.
Phase 1 Dose-Escalation Study of a siRNA Targeting the RTP801 Gene in AgeRelated Macular Degeneration Patients. Eye (Lond). 2012;26:1099-10.
13
75.
Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Klamerus KJ, Chi-Burris K,
Yan E, Paggiarino DA, Rosenblatt I, Aitchison R, Erlich SS; MONET Clinical
Study Group. Evaluation of the siRNA PF-04523655 versus Ranibizumab for the
Treatment of Neovascular Age-related Macular Degeneration (MONET Study).
Ophthalmology. 2012;119:1867-73.
76.
Nguyen QD, Campochiaro PA, Shah SM, Browning DJ, Hudson HL, Sonkin PL,
Hariprasad SM, Kaiser PK, Slakter J, Haller JA, Do DV, Mieler W, Chu K,
Ingerman A, Vitti R, Berliner AJ, Cedarbaum And The Clear-IT 1 Investigators.
Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients
with Neovascular Age-Related Macular Degeneration. Journal of Ocular
Pharmacology and Therapeutics. 2012; 28:581-588.
77.
Hatef E, Khwaja A, Rentiya Z, Ibrahim M, Shulman M, Turkcuoglu P, Sepah Y,
Wang J, Channa R, Bittencourt M, Akhtar A, Heo J, Do DV, Nguyen QD.
Comparison of Time Domain and Spectral Domain Optical Coherence Tomography
in Measurement of Macular Thickness in Macular Edema Secondary to Diabetic
Retinopathy and Retinal Vein Occlusion. Journal of Ophthalmology; 2012; [Epub].
78.
Campbell JP, Leder HA, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M,
Bittencourt M, Channa R, V Do D, Nguyen QD. Wide-field Retinal Imaging in the
Management of Noninfectious Posterior Uveitis. American Journal of
Ophthalmology. 2012; 154: 908-911..
79.
Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ,
Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ,
Nguyen QD, Calabresi PA. Microcystic Macular Edema, Thickness of the Inner
Nuclear Layer of the Retina, and Disease Characteristics in Multiple Sclerosis: A
Retrospective Study. Lancet Neurology. 2012; 11:1021.
80.
Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G,
Campochiaro PA for the READ-2 Study Group. Ranibizumab for Edema of the
Macula in Diabetes (READ) Study: 3-Year Outcomes and the Need for Prolonged
Frequent Treatment. Archives of Ophthalmology. 2012; 1-7.
81.
Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, ChiBurris K, Yan E, Paggiarino DA, Rosenblatt I, Aitchison R, Erlich SS for the
DEGAS Clinical Study Group. Dose-Ranging Evaluation of Intravitreal siRNA
PF-04523655 for Diabetic Macular edema (the DEGAS study). Investigative
Ophthalmology and Visual Sciences. 2012; 53:7666-74.
82.
Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof
B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y,
14
Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, SchmidtErfurth U for the VIEW 1 and VIEW 2 Study Groups. Intravitreal Aflibercept
(VEGF Trap-Eye) in Wet Age-Related Macular Degeneration. Ophthalmology.
2012; 119: 2537-2548.
83.
Do DV, Greenwald L, Ibrahim M, Sepah Y, Nguyen QD. Choroidal
Neovascularization Regression on Fluorescein Angiography after VEGF Blockade.
Case Reports in Ophthalmology. 2012; 3: 384-388.
84.
Campochiaro PA, Nguyen QD, Hafiz G, Bloom S, Brown DM, Busquets M, Ciulla
T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane FE for the FAMOUS
Study Group. Aqueous Levels of Fluocinolone Acetonide after Administration of
Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants.
Ophthalmology. 2012
85.
Oh J, Sotirchos ES, Saidha S, Ibrahim M, Sepah Y, Nguyen QD, Calabresi PA. In
Vivo Demonstration of Homonymous Hemimacular Loss of Retinal Ganglion Cells
due to a Thalamic Lesion using Optical Coherence Tomography. JAMA Neurology.
2013; 70: 410-411.
86.
Ibrahim MA, Do DV, Sepah YJ, Shah SM, Van Anden E, Hafiz G, Donahue JK,
Rivers R, Balkissoon J, Handa JT, Campochiaro PA, Nguyen QD. Vascular
Disrupting Agent for Neovascular Age-Related Macular Degeneration: A Pilot
Study of the Safety and Efficacy of Intravenous Combretastatin A-4 Phosphate.
BMC Pharmacology and Toxicology. 2013; 14:7.
87.
Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, Moradi A, Liu H,
Ibrahim M, Do DV, Coulantuoni E, Nguyen QD. Association of Retinal
Sensitivity to Integrity of Photoreceptor Inner/Outer Segment Junction in Patients
with Diabetic Macular Edema. Ophthalmology. 2013.
88.
Leder HA, Campbell JP, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M,
Bittencourt M, Channa R, Do DV, Nguyen QD. Ultra-Wide-Field Retinal Imaging
in the Management of Non-Infectious Retinal Vasculitis. Journal of Ophthalmic
Inflammation and Infection. 2013.
89.
Nguyen QD, Ibrahim MA, Watters A, Bittencourt M, Yohannan J, Sepah YJ, Dunn
JP, Naor J, Shams N, Shaikh O, Leder HA, Do DV. Ocular Tolerability and
Efficacy of Intravitreal and Subconjunctival Injections of Sirolimus in Patients with
Non-Infectious Uveitis: Primary 6-Month Results of the SAVE Study. Journal of
Ophthalmic Inflammation and Infection. 2013.
90.
Sotirchos ES, Saidha S, Byraiah G, Mealy MA, Ibrahim MA, Sepah YJ, Newsome
SD, Ratchford JN, Frohman EM, Balcer LJ, Crainiceanu CM, Nguyen QD, Levy
15
M, Calabresi PA. In-Vivo Identification of Morphologic Retinal Abnormalities in
Neuromyelitis Optica. Neurology. 2013.
91.
Do DV, Nguyen QD, Khwaja AA, Channa R, Sepah YJ, Sophie R, Hafiz G,
Campochiaro PA, and the READ-2 Study Group. Ranibizumab for Edema of the
mAcula in Diabetes Study: 3-year Outcomes and the Need for Prolonged Frequent
Treatment. JAMA Archives of Ophthalmology. 2013;131:139-45.
92.
Burkholder BM, Wang J, Dunn JP, Nguyen QD, Thorne JE. Postoperative
Outcomes after Fluocinolone Acetonide Implant Surgery in Patients with Birdshot
Chorioretinitis and Other Types of Posterior and Panuveitis. Retina. 2013.
EDUCATIONAL PUBLICATIONS
Invited Peer-Reviewed Review Articles
1.
Nguyen QD, Foster CS. “Cicatricial Pemphigoid: Diagnosis and Treatment.”
International Ophthalmology Clinics. Winter 1996; 36 (1): 41-60.
2.
Nguyen QD, Foster CS. “Systemic Lupus Erythematosus and the Eye.”
International Ophthalmology Clinics. Winter 1998; 38 (1): 33-60.
3.
Nguyen QD, Foster CS. “Saving the Vision of Children with Juvenile Rheumatoid
Arthritis-Associated Uveitis.” JAMA. 1998; 280: 1133-1136.
4.
Nguyen QD, Foster CS. “Scleral Homograft in the Management of Necrotizing
Scleritis.” International Ophthalmology Clinics. Winter 1999; 39: 109-131.
5.
Nguyen QD, Tawansy K, Hirose T. “Recent Advances in Retinopathy of
Prematurity.” International Ophthalmology Clinics. Fall 2001; 41: 129-151.
6.
Kruger EF, Nguyen QD, Ramos-Lopez M, Lashkari K. “Proliferative
Vitreoretinopathy after Trauma.” International Ophthalmology Clinics. 2002; 42:
129-143.
7.
Nguyen QD, Do DV. “Retinal Vasculitis: Current Concepts in Diagnosis and
Management.” Contemporary Ophthalmology. 2002; 1 (12): 1-16.
8.
Nguyen QD, Do DV. “Diabetic Retinopathy: An Overview for NonOphthalmologists.” Advanced Studies in Medicine. 2003; 3: 214-222.
9.
Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT.
Treating Chronic Noninfectious Posterior Segment Uveitis: the Impact of
Cumulative Damage – Proceedings of an Expert Panel Roundtable Discussion.
16
Retina. 2006; October: Supplement 1-16.
10.
Brumm M, Nguyen QD. Fluocinolone Acetonide Intravitreal Sustained Release
Device - A New Addition to the Armamentarium of Uveitic Management.
International Journal of Nanomedicine. 2007; 2: 55-64.
11.
Khurana RN, Do DV, Nguyen QD. Anti-VEGF Approach for Diabetic Macular
Edema. International Ophthalmology Clinics. 2009; 49(2):109-19.
12.
Gomes Bittencourt M, Sepah YJ, Do DV, Agbedia O, Akhtar A, Liu H, Akhlaq A, Annam
R, Ibrahim M, Nguyen QD. New Treatment Options for Non-Infectious Uveitis.
Developmental Ophthalmology. 2012; 51:134-61.
13.
Heo J, Sepah YJ, Yohannan J, Renner M, Akhtar A, Gregory A, Shulman M, Do DV,
Nguyen QD. The Role of Biologic Agents in the Management of Non-Infectious Uveitis.
Expert Opinion in Biological Therapy. 2012;12:995-1008.
Editorials
1.
Pan RJD and Nguyen QD. Preparing for Practice in the New Health Care System.
JAMA. 1996; 276 (9): 666.
2.
Kashani AH, Zimmer-Galler IE, Shah SM, Dustin L, Do DV, Eliott, Haller JA,
Nguyen QD. Retinal Thickness Analysis by Race, Gneder, and Age Using Stratus
OCT. American Journal of Ophthalmology. 2010; 150:288-290.
Peer-Reviewed Case Reports
1.
Uy HS, Nguyen QD, Durand ML, Paton B, Foster CS. “Infectious Crystalline
Keratopathy and Endophthalmitis Secondary to Mycobacterium abscessus in a
Monocular Patient with Stevens-Johnson Syndrome.” American Journal of
Ophthalmology. 1999; 127: 209-210.
2.
Do DV, Rismondo V, Nguyen QD. “Reversible Cortical Blindness in
Preeclampsia.” American Journal of Ophthalmology. 2002; 134: 916-918.
3.
Margalit E, Sung JU, Do DV, Yohay K, Nguyen QD. “Panuveitis in Association
with Pseudotumor Cerebri.” Journal of Child Neurology. 2005; 20: 234-236.
4.
Nguyen QD, Shah SM, Tatlipinar S, Do DV, Van Anden E, Campochiaro PA.
Bevacizumab Suppresses Choroidal Neovascularization Due to Pathologic Myopia.
British Journal of Ophthalmology. 2005; 89: 1368-1370.
5.
Tatlipinar S, Shah SM, Nguyen QD. OCT Features of Sub-Internal Limiting
Membrane Hemorrhage and Preretinal Membrane in Valsalva Retinopathy.
17
Canadian Journal of Ophthalmology. 2007; 42: 129-130.
6.
Pérez-Alvarez MJ, González-Guijarro J, Adán-Civera A, Moreno-López M,
Williams DF, Nguyen QD. Diagnostic and Therapeutic Challenges: Retinitis.
Retina. 2007; 27: 509-513.
7.
Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Do DV, Nguyen QD. Atypical
Bartonella hensalae Chorioretinitis in an Immunocompromised Patient. Ocular
Immunology and Inflammation. 2008; 16(1): 45-49.
8.
Park SS, Holz HA, Ravage ZB, Merrill PT, Nguyen QD. Diagnostic and
Therapeutic Challenges: Chorioretinitis and Panuveitis. Retina. 2008; 27: 660-664.
9.
Marcus EI, Do DV, Shah SM, Biswas J, Levinson R, Nguyen QD. Diagnostic and
Therapeutic Challenges: Granulomatous Panuveitis. Retina. 2008; 28: 1544-1549.
10.
Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Do DV, Nguyen QD. Atypical
Bartonella hensalae Chorioretinitis in an Immunocompromised Patient. Ocular
Immunology and Inflammation. 2008; 16(1): 45-49.
11.
Park SS, Holz HA, Ravage ZB, Merrill PT, Nguyen QD. Diagnostic and
Therapeutic Challenges: Chorioretinitis and Panuveitis. Retina. 2008; 27: 660-664.
12.
Marcus EI, Do DV, Shah SM, Biswas J, Levinson R, Nguyen QD. Diagnostic and
Therapeutic Challenges: Granulomatous Panuveitis. Retina. 2008; 28: 1544-1549.
13.
Channa R, Khurana RN, Speicher MA, Shah SM, Do D, Levinson R, Goldstein
DA, Nguyen QD. Diagnostic and Therapeutic Challenges: The Case of the Man
from Sierra Leone. Retina. 2009; 29(7):1045-51.
14.
Sabet-Peyman EJ, Nguyen QD, Do DV. Cystoid Macular Edema Responds to
Intravitreal Triamcinolone and Rebounds after Intravitreal Bevacizumab.
Ophthalmic Surgery and Lasers Imaging. 2009; 40(4):413-5.
15.
Sabet-Peyman EJ, Eberhart CG, Janjua K, Shah SM, Do DV, Nguyen QD.
Persistent Intermediate Uveitis Associated with Latent Manifestation of Facial
Larage B-Cell Non-Hodgkin Lymphoma. Ocular Immunology and Inflammation.
2009; 17: 322-24.
16.
Khurana RN, Leder HA, Nguyen QD, Do DV. Enterococcus casseliflavus
Endophthalmitis Associated with a Horse Tail Injury. Archives of Ophthalmology.
2009; 127: 1551-52
18
17.
Fallano KA, Ibrahim M, Nguyen QD, Do DV. Progressive Changes from
Idiopathic Macular Telangiectasia Seen with Spectral Domain Optical Coherence
Tomography. Canadian Journal of Ophthalmology. 2010; 45: 1-2.
18.
Kim BJ, Do DV, Arevalo F, Van Gelder RN, Nguyen QD. Diagnostic and
Therapeutic Challenges: Acute Onset Panuveitis. Retina. 2010; 30: 364-8.
19.
Hatef E, Wang J, Ibrahim M, Turkcuoglu P, Khwaja A, Channa R, Suan EP,
Dibernado C, Sepah YJ, Do DV, Nguyen QD. Nodular Sclerochoroidopathy
Simulating Choroidal Malignancy. Ophthalmic Surgery Lasers Imaging. 2010; 41.
20.
Hatef E, Ibrahim M, Nguyen QD, Do DV, Davis MJ, Rezaei KA, Kovach JL.
Diagnostic and Therapeutic Challenges. Retina. 2011 March.
21.
Vance SK, Freund KB, Wenick AS, Nguyen QD, Holland GN, Kreiger AE.
Diagnostic and Therapeutic Challenges. Retina. 2011 April.
22.
Le-Nguyen XT, Lee TK, Do DV, Sepah YJ, Nguyen QD, Rao NA, VasconcelosSantos DV, Goldstein DA. Diagnostic and Therapeutic Challenges. Retina. 2011
June.
23.
Chen LY, Kesen MR, Ghafourian A, Nguyen QD, Eberhart CG, Do DV. Isolated
Endogenous Nocardia Endophthalmitis after Immunosuppression. Journal of
Ophthalmic Inflammation and Infection. 2012; [Epub]
24.
Yohannan J, Channa R, Dibernardo CW, Zimmer-Galler IE, Ibrahim M, Sepah YJ,
Bittencourt M, Do DV, Nguyen QD. Sclerochoroidal Calcifications Imaged Using
Enhances Depth Imaging Optical Coherence Tomography. Ocular Immunology
and Inflammation. 2012; 20:190-192.
25.
Wenick AS, Paskowitz DM, Tauqir MZ, Nguyen QD. Choroidal
Neovascularization and Bevacizumab Therapy in Aicardi Syndrome. Graefes Arch
Clinical and Experimental Ophthalmology. 2012; [Epub].
26.
Tauqir MZ, Shulman M, Bittencourt M, Sepah YJ, Ibrahim M, Do DV, Nguyen
QD, Foster CS, Vora RA, Albini TA. Diagnostic and Therapeutic Challenges:
Retinal Vasculitis. Retina. 2013.
Letters and Correspondence
1.
Nguyen QD, Shah SM, Campochiaro PA. Oxygen and Diabetic Retinopathy.
Investigative Ophthalmology and Visual Science Online, January, 2005.
19
2.
Do DV, Nguyen QD. Reply Letter Regarding Persistent Diabetic Macular Edema
is Associated with Elevated Hemoglobin A1C. American Journal of
Ophthalmology; 140: 961, 2005.
3.
Kashani AH, Zimmer-Galler I, Shah SM, Do DV, Nguyen QD, Dustin L, Eliott D,
Haller J. Reply Letter Regarding Retinal Thickness Analysis by Race, Gender, and
Age using Stratus OCT. American Journal of Ophthalmology. 2010; 150; 288290.
4.
Brown DM, Nguyen QD, Ehrlich JS for the RISE and RIDE Research Group.
Ranibizumab for Diabetic Macular Edema. Author Reply. Ophthalmology. 2013;
120: 221-222.
Book Chapters
1.
Nguyen QD. “Youth from Every Quarter” in Transitions, Exeter Remembered,
1961-1987. B Eggers, P Greer, C Robinson, and D Weber, Editors. Phillips Exeter
Academy Press, Exeter, New Hampshire, 1990.
2.
Foster CS and Nguyen QD. “Adamantiades-Behcet’s Disease” in Principles and
Practice of Ophthalmology, Second Edition. DM Albert and FA Jakobiec, Editors.
W.B. Saunders, Philadelphia, Pennsylvania 1999.
3.
Nguyen QD and Foster CS. “Tectonic Procedures” in Ophthalmic Surgery:
Principles and Techniques. DM Albert, Editor. Blackwell Science, Malden,
Massachusetts, 1999.
4.
Nguyen QD and Foster CS. “The Red Eye” in Pediatric Ophthalmology. PF
Gallin, Editor. Thieme, New York, New York, 2000.
5.
Jabs DA and Nguyen QD. “Sarcoidosis” in Retina, Third Edition. SJ Ryan,
Editor. C.V. Mosby, St. Louis, Missouri, 2000.
6.
Jabs DA and Nguyen QD. “Toxoplasmosis” in Retina, Third Edition. SJ Ryan,
Editor. C.V. Mosby, St. Louis, Missouri, 2000.
7.
Nguyen QD. “Traumatic Uveitis” in Diagnosis and Treatment of Uveitis. CS
Foster and A Vitale, Editors. W.B. Saunders, Philadelphia, Pennsylvania, 2002.
8.
Nguyen QD, Do DV. “Areas of Fundus Whitening: Geographic Whitening” in
Clinical Pathways in Vitreoretinal Disease. ME Hartnett and S Steidl, Editors.
Thieme Medical Publishers, New York, New York, 2003.
9.
Nguyen QD. “Pathology and Pathogenesis of Scleritis and Sclerokeratitis” in The
Sclera and Systemic Disorders. PG Watson, BL Hazleman, CE Pavesio, WR
20
Green, Editors. Butterworth and Heineman, London, 2004. (Dr. Nguyen was one of
the 6 contributors to the textbook).
10.
Nguyen QD. “Scleritis in Relation to Connective Tissue Disorders” in The Sclera
and Systemic Disorders. Second Edition. PG Watson, BL Hazleman, CE Pavesio,
WR Green, Editors. Butterworth and Heineman, London, 2004. (Dr. Nguyen was
one of the 6 contributors to the textbook).
11.
Nguyen QD. “Tectonic Procedures” in Clinical Atlas of Procedures in Ophthalmic
Surgery. DM Albert and M Lucarelli, Editors. AMA Press, Chicago, Illinois,
2004.
12.
Nguyen QD and Do DV. “Uveitis Associated with Juvenile Idiopathic Arthritis” in
Current Ocular Therapy, Sixth Edition. Roy and Fraunfelder, Editors. Elsevier,
Ltd., United Kingdom, 2007.
13.
Do DV, Nguyen QD, Shah MS, Haller JA. “Ranibizumab for the Treatment of
Diabetic Macular Edema” in Retinal Vascular Diseases, 1st Edition. Joussen,
Editor. Elsevier, Ltd. United Kingdom, 2008.
14.
Do DV, Nguyen QD, Haller JA. “Retinal Arterial Macroaneurysms” in Principles
and Practice of Ophthalmology, 3rd Edition. Albert and Miller, Editors. Elsevier,
Ltd. United Kingdom, 2008.
15.
Campbell JP, Do DV, Nguyen QD. “Macular Edema Associated with Ocular
Inflammatory Diseases” in Macular Surgery, 2nd Edition. Quiroz-Mercado and
Kerrison, Editors. Wolters Kluwer, 2011.
16..
Ibrahim M, Channa R, Nguyen QD. “Anti-Angiogenesis Drugs for Neovascular
AMD Currently in Clinical Trials” in Therapy of Ocular Angiogenesis: Principles
and Practice. Das and Friberg, Editors. Lippincott Williams and Wilkins, 2011.
17.
Kim BJ, Do DV, Nguyen QD. “Ranibizumab and Other VEGF Antagonists for
Diabetic Macular Edema” in Visual Dysfunction in Diabetes. Tombran-Tink,
Barnstable, and Gardner, Editors. Human Press, 2012.
Books
Nguyen QD, Rodrigues EB, Farah M, Mieler W, Editors. Retinal
Pharmacotherapy, 1st Edition. Elsevier, Ltd. United Kingdom, 2010.
TEACHING
21
Classroom Instruction
Lecture Titles
1. Basic Eye Exam
The lecture (90 minutes in length) is given 6 times a year at the Wilmer Eye Institute, as
part of the Introduction to Ophthalmology Clerkship for medical students (mainly second
and third year students).
Role: Principal Instructor
2. Diagnosis and Management of Retinal Detachment
The lecture (120 minutes in length), which is delivered as a seminar with maximum
participation from the students, is given 4-5 times a year at the Wilmer Eye Institute, as
part of the Advanced Clerkship in Ophthalmology for medical students (mainly third and
fourth year students).
Role: Principal Instructor
3. Diagnosis and Management of Retinal Vasculitis
The lecture (60 minutes in length) is given annually to the residents at the Wilmer Eye
Institute as part of the lecture series in diseases of the retina and vitreous. Residents from
all years attend the lecture.
Role: Principal Instructor
4. White Dot Syndromes: How Do You Tell Them Apart or Can You?
The lecture (60 minutes in length) is given annually to the residents at the Wilmer Eye
Institute as part of the lecture series in diseases of the retina and vitreous. Residents from
all years attend the lecture.
Role: Principal Instructor
Clinical Instruction
1. Teaching of Fellows Trained in Medical and Surgical Diseases of the Retina and
Vitreous, Retina Division, Wilmer Eye Institute
Supervising and teaching fellows three times a week when they rotate with me in my clinics
and participate with me in surgery.
2. Teaching of Residents in Ophthalmology on Diseases of the Retina and Vitreous, and
Uveitis, Wilmer Eye Institute
Teaching residents weekly when they rotate with me in my clinics and participate with me
in surgery.
MENTORING
22
Mentoring of Johns Hopkins University and Other University Undergraduate and Medical
Students
Serving as faculty mentor to undergraduate and medical students who are interested in
pursuing a career in ophthalmology. In this capacity, I work very closely with the students
to advise them on their courses, on their residency application process, as well as to
provide them with opportunities for research activities. I have had the opportunity to
mentor several undergraduate and medical students during the past several years.
Advisees/Mentees
Date
Name
Degree
Present Position
2005-2006
Amir Kashani
MD
2006-2007
2006-2007
2006-2008
Adam Gerstenblith MD
Matthew Brumm
MD
Peter Campbell
MD
2007-2009
Kashif Janjua
MD
2008-2012
Jordan Ambrose
BS
2009-2010
Matthew Shulman
BS
2008-2010
Aymen Rashid
BS
2009-
Hyun Soo Jang
2009-
Jithin Yohannan
BS
2010-
Abeer Akhtar
BS
Fellow in Retina, Associated Retinal
Consultants, Michigan
Fellow in Retina, Wills Eye Institute
Practicing Ophthalmologist, Michigan
Resident in Ophthalmology, Wilmer
Eye Institute
Attending in Internal Medicine
University of Medicine and Dentistry
of New Jersey
Medical Student, University of
Maryland Class of 2012
Medical Student, University of
Maryland Class of 2014
Medical Student, Johns Hopkins
University Class of 2014
Undergraduate Student, Johns Hopkins
University
MPH Student, Johns Hopkins School
of Public Health Class of 2012
Medical Student, Johns Hopkins
University Class of 2013
Medical Student, Harvard Medical
Student Class of 2016
Current Post-Doctoral Research Fellows (who are being mentored directly by me)
Owhofasa Agbedia, MD, MPH (Ibadan, Nigeria)
Rachel Annam, MD, MPH (Abuja, Nigeria)
Millena Bittencourt, MD (Sao Paulo, Brazil)
Daniel Ferraz, MD (Sao Paulo, Brazil)
Mostafa Hanout, MD (Cairo, Egypt)
Mohamed Ibrahim, MD (Cairo, Egypt)
23
Hongting Liu, MD (Beijing, China)
Ahmadreza Moradi, MD (Tehran, Iran)
Yasir Sepah, MD (Peshawar, Pakistan)
Past Post-Doctoral Research Fellows (who were mentored by me at the Wilmer Eye
Institute)
Roomasa Channa, MD: Residency in Ophthalmology, Wilmer Eye Institute, Johns
Hopkins University School of Medicine starting July 2012
Elham Haftef, MD: Residency in Preventive Medicine, Johns Hopkins University School
of Medicine and School of Public Health starting July 2012
Afsheen Khwaja, MD: Associate Medical Director, Santen Pharmaceuticals, Inc.
Jangwon Heo, MD: Assistant Professor of Ophthalmology, Seoul National University,
Seoul, Korea
Peykan Turkcuoglu, MD: Associate Professor of Ophthalmology, Inonu University
School of Medicine, Malatya, Turkey
Jianmin Wang, MD: Associate Professor of Ophthalmology, the Second Hospital of
Hebei Medical University, Hebei, China
EDUCATIONAL PROGRAM BUILDING AND LEADERSHIP
I have completed the following professional development seminars sponsored by the Office
of Faculty Development of Johns Hopkins University in an effort to improve my leadership
skills and abilities, which I believe will be beneficial for my academic career as well as for
my interaction and collaboration with colleagues and staff members.
1. Hiring Staff: Tips and Tools for Faculty
2. Speak Like a Pro
3. How to Succeed in Managing Your Staff and Working with Your Colleagues
CLINICAL ACTIVITIES
MEDICAL LICENSURE
1994
1997
National Board of Medical Examiners
Massachusetts Medical License number 153489
24
1997
1998
1998
1998
2002
2013
United States DEA License number BN 5327487
District of Columbia Medical License number MD 30860
Maryland Medical License number D 0053275
Virginia Medical License number 0101057360
Diplomate of the American Board of Ophthalmology
Nebraska Medical License number 27206
CLINICAL RESEARCH ACTIVITIES: PARTICIPATION
IN
CLINICAL TRIALS
1.
Principal Investigator Supplemental Inspired Oxygen for
Hypoxia-Mediated Retinal Diseases
Sponsored by the National Eye Institute
2001-2006
2.
Co-Investigator
A Phase 2 Randomized, Multicenter
Controlled Trial of Octreotide Acetate
(Sandostatin LAR) in the Treatment of
Diabetic Retinopathy
Sponsored by Novartis, Inc.
2001-2003
3.
Co-Investigator
A Multicenter, Randomized, Double2001-2004
Masked, Placebo-Controlled Parallel-Group
Dose Finding Phase II Study of PKC412
(50, 100, 150 mg/day) in Patients with
Diabetic Macular Edema
Sponsored by CIBA Vision/Novartis, Inc.
4.
Co-Investigator
A Phase 2/3 Randomized, Double Masked 2002-2004
Controlled, Multi-Center Comparative Trial
to Establish the Safety and Efficacy of
Intravitreal EYE001 (Anti-VEGF Pegylated
Aptamer) in Patients with Exudative AgeRelated Macular Degeneration
Sponsored by EyeTech, Inc.
5.
Co-Investigator
A Phase 2 Randomized, Multicenter,
2002-2003
Dose-Ranging, Controlled, Parallel-Group
Trial to Assess the Safety and Efficacy of
Dexamethasone Posterior Drug Delivery
System (DEX PS DDS) in the Treatment
of Persistent Macular Edema
Sponsored by Oculex Pharmaceuticals, Inc.
6.
Co-Investigator
Early Treatment for Retinopathy of
Prematurity
Sponsored by the National Eye Institute
2002-2004
25
7.
Co-Investigator
GV-003.001 An Open-Label, Phase I,
Single Administration, Dose-Escalation
Study of AdGV PEDF.11D in Neovascular
Age-Related Macular Degeneration
Sponsored by GenVec, Inc.
2002-2006
8.
Principal Investigator An Open Label, Pilot (Phase I/II), Dose2003-2005
Escalation Safety and Tolerability Study
of Combretastatin A4 Phosphate in
Patients with Neovascular Age-Related
Macular Degeneration
Sponsored by Foundation Fighting Blindness, Inc.
9.
Co-Investigator
10.
Principal Investigator An Exploratory Study of the Safety,
2004-2006
Tolerability, and Biological Activity of
Intravenously Administered VEGF Trap in
Patients with Neovascular Age-Related
Macular Degeneration
Sponsored by Regeneron, Inc.
11.
Principal Investigator The Standard Care versus Corticosteroid
2004-2009
for Retinal Vein Occlusion (SCORE) Study
Sponsored by the National Eye Institute
12.
Principal Investigator An Exploratory Study of the Safety,
2004-2006
Tolerability, and Biological Activity of
Intravenously Administered VEGF Trap in
Patients with Diabetic Macular Edema
Sponsored by Regeneron, Inc.
13.
Principal Investigator A Pilot, Open-Label, Dose-Escalation Study 2004-2006
of the Safety, Tolerability, and Efficacy of
Multiple Intravitreal Injections of
Ranibizumab in Subjects with Macular
Edema Secondary to Diabetes Mellitus
Sponsored by Juvenile Diabetes Research Foundation
A Phase III, Multicenter, Randomized,
2003-2006
Double-Masked, Sham Injection-Controlled
Study of the Efficacy and Safety of rhuFab V2
(Ranibizumab) in Subjects with Minimally
Classic or Occult Subfoveal Neovascular AgeRelated Macular Degeneration
Sponsored by Genentech, Inc. & Novartis AG
26
14.
Principal Investigator A Randomized, Double-Masked, Parallel 2005-2006
Group Multicenter, Dose Ranging Pilot Study of Denufosol
Tetrasodium (INS37217) Intravitreal Injection in
Subjects with Uveitis Associated Cystoid Macular Edema
Sponsored by Inspire Pharmaceuticals, Inc.
15.
Principal Investigator An Exploratory Study of the Safety,
2005-2012
Tolerability, and Biological Effect of
Intravitreal Administration of VEGF Trap in
Patients with Neovascular Age-Related
Macular Degeneration
Sponsored by Regeneron, Inc.
16.
Principal Investigator Intravenous Bevacizumab for Choroidal
Neovascularization not Secondary to AgeRelated Macular Degeneration
Sponsored by Retina Research Fund
17.
Co-Investigator
A Randomized, Double-Masked, Parallel 2006-2011
Group, Multi-Center, Dose-Finding Comparison
of the Safety and Efficacy of ASI-001A 0.5 µg/day
and ASI-001B 0.2 µg/day Fluocinolone Acetonide
Intravitreal Inserts to Sham Injection in Subjects with
Diabetic Macular Edema
Sponsored by Alimera, Inc.
18.
Co-Investigator
A 3-Year, Phase 3, Multicenter, Masked,
2006Randomized, Sham-Controlled Trial to Assess the
Safety and Efficacy of 700 µg and 350 µg
Dexamethasone Posterior Segment Drug Delivery
System (DEX PS DDS) Applicator System in the
Treatment of Patients with Diabetic Macular Edema
Sponsored by Allergan, Inc.
19.
Co-Investigator
A Randomized, Open-Label Study of the
2006-2009
Safety, Tolerability, and Bioactivity of Intravitreal
Ranibizumab in Subjects with Macular Edema Secondary
to Retinal Vein Occlusions
Sponsored by Genentech, Inc.
20.
Co-Investigator
A Multi-Center, Randomized, Double2006-2008
Masked, Placebo Controlled, Sequential Dose
Response Study of Intravitreally Administered Plasmin
for the Creation of a Posterior Vitreous Detachment (PVD)
Sponsored by Bausch and Lomb, Inc.
2005-2007
27
21.
Co-Investigator
A Randomized, Double-Masked, Multi2007-2009
Center Phase I/II study of the Safety of PTK787
Administered in Conjunction with Photodynamic Therapy
with Visudyne® to Patients with Predominantly Classic,
Minimally Classic or Occult with no Classic Subfoveal
Choroidal Neovascularization Secondary to Age-Related
Macular Degeneration
Sponsored by Novartis, Inc.
22.
Co-Investigator
A Multi-Center, Randomized Trial of
2007Lutein, Zeaxanthin, and Omega-3 Fatty Acids in AgeRelated Macular Degeneration
Sponsored by the National Eye Institute
23.
Co-Investigator
Phase 2 Study of the Safety and Bioactivity 2007-2009
of Topical Ocular Mecamylamine for the
Treatment of Diabetic Macular Edema
Sponsored by the Juvenile Diabetes Research
Foundation and Comentis, Inc.
24.
Principal Investigator A Double-Masked, Placebo-Controlled,
2007-2009
Parallel-Group, Multi-Center, Dose-Ranging Study
to Assess the Efficacy and safety of LX-211 as
Therapy in Subjects with Active Sight Threatening
Non-Infectious Anterior Uveitis; Clinically Quiescent
Sight Threatening, Non-Infectious Intermediate-, Anterior
and Intermediate-, Posterior-, or Pan-Uveitis; or Active
Sight Threatening, Non-Infectious Anterior Uveitis
Sponsored by Lux Biosciences, Inc.
25.
Principal Investigator A Randomized, Double Masked, Active
2007-2012
Controlled Phase III Study of the Efficacy, Safety, and
Tolerability of Repeated Doses of Intravitreal VEGF Trap
in Subjects with Neovascular Age-Related Macular
Degeneration
Sponsored by Regeneron Pharmaceuticals, Inc.
26.
Principal Investigator A Phase 1 Open-Label, Dose Escalation
2008-2010
Trial of REDD14NP in Patients with Choroidal
Neovascularization Secondary to Exudative
Macular Degeneration
Sponsored by Pfizer, Inc.
27.
Principal Investigator An Open-Label Study to Assess the Effect
of Two Doses of AIN457 in Patients with
2008-2010
28
Non-Infectious Uveitis
Sponsored by Novartis, Inc.
28.
Principal Investigator A Multicenter, Single Sequence, Open-Label 2009-2011
Study to Assess the Tolerability, Safety and Efficacy of
AEB071 in the Treatment of Patients with
Macular Edema associated with Non-Infectious Intermediate
Uveitis, Posterior Uveitis, or Panuveitis
Sponsored by Novartis, Inc.
29.
Principal Investigator Sirolimus as Novel Approach for Uveitis: 2009the SAVE Study
Sponsored by Uveitis Research Fund at Wilmer, MacuSight, Inc.,
and Santen, Inc.
30.
Principal Investigator A Phase 2, Randomized, Double-Masked, 2010-2012
Controlled Study to Establish the Safety and Efficacy
of E10030 (Anti-PDGF Pegylated Aptamer) Given in
Combination with Lucentis® in Subjects with Neovascular
Age-Related Macular Degeneration
Sponsored by Ophthotech, Inc.
31.
Principal Investigator A Multicenter Study of the Efficacy and Safety of the
HumanAnti-TNF Monoclonal Antibody Adalimumab in
Subjects Requiring High Dose Corticosteroids for Active
Non-Infectious Intermediate, Posterior, or pan-Uveitis
Sponsored by Abbott, Inc.
32.
Principal Investigator A Multi-Center, Double-Masked, Parallel 2011Group, Placebo Controlled Study to Assess the Efficacy and
Safety of Voclosporin as Therapy in Subjects with Active
Non-Infectious Intermediate, Posterior, or Pan-Uveitis
Sponsored by Lux Biosciences, Inc.
33.
Principal Investigator MD7114987, An Open-label, Phase 2a Study 2011-2012
to Evaluate Pazopanib Eye Drops Administered for 12 weeks
To Evaluate Patients with Neovascular Age-related Macular
Degeneration
Sponsored by Glaxo-Smith-Kline, Inc.
34.
Principal Investigator A Phase 2, Multi-center, Randomized,
2011-2012
Placebo-controlled, Parallel-Group Study to Investigate the
Safety, Tolerability, Efficacy, Pharmacokinetics and
Pharmacodynamics of GSK933776 in Adult Patients with
Geographic Atrophy (GA) secondary to Age-related Macular
29
Degeneration (AMD).
Sponsored by Glaxo-Smith-Kline, Inc.
ORGANIZATIONAL ACTIVITIES
INSTITUTIONAL ADMINISTRATIVE APPOINTMENTS
Johns Hopkins University School of Medicine
2003-2005
Member, JH SOM Medical School Council Committee on
Advancement of Junior Faculty – chaired by Patricia Thomas, MD,
Associate Dean for Curriculum. This Committee worked with chairs
of clinical departments to determine the mechanisms and
infrastructure available in each department to help the mentoring and
promotion of Assistant Professorship to Associate Professorship.
2003-
Member, Admissions Committee for the School of Medicine –
chaired by James Weiss, MD, Professor of Medicine and Associate
Dean for Admission. This Committee interviews student applicants
to JH School of Medicine (SOM) and meets in the Fall, Winter, and
early Spring to select the best possible students for the medical
school.
2006-
Member, Educational Policy and Curriculum Committee (EPCC) –
chaired by David Nichols, MD, Vice Dean for Education. This
Committee is made up of leaders from core basic science courses
and clinical clerkships. It oversees and governs the policy and
conducts of courses and curriculum for all medical students. My role
as a member of the EPCC Committee, with particular focus on
Ophthalmology, requires 5% effort, which is provided by the SOM.
2006-2010
Member, Student Assessment and Program Evaluation (SAPE)
Committee – chaired by Pamela Lipsett, MD, Professor of Surgery.
This Committee reviews and evaluates each core basic course and
clinical clerkship in the SOM, based on reports and interviews with
the course directors, chairperson of the department, as well as
medical students. The SAPE makes recommendations for
improvements to the Vice Dean for Education and course directors.
My role as a member of the SAPE Committee requires 5% effort,
which is provided by the SOM.
2006-2009
Co-Chair, Subcommittee on Rewards and Compensation for
Teaching Activities, the Abeloff Committee on Educational Value
and Rewards – chaired by the late Martin Abeloff, MD, Professor of
30
Medicine and Joseph Cofrancesco, MD, Associate Professor of
Medicine, and overseen by Janice Clement, PhD, Vice Dean for
Faculty and Edward Miller, MD, Dean of the School of Medicine.
This Committee is charged by Dean Miller to document and evaluate
faculty education efforts and to determine the most appropriate
mechanism to compensate for such effort, adhering to the principles
set forth by the School of Medicine.
2011-
Director of Medical Student Education in Ophthalmology. The
Director oversees the ophthalmology curriculum for the medical
students, collaborating with the faculty members at the Wilmer Eye
Institute as well as the Office of the Vice Dean for Education. The
Director also works with and advises medical students who are
interested in entering a career in ophthalmology.
OTHER ADMINISTRATIVE APPOINTMENTS
American Academy of Ophthalmology
2003-2005
Chair, Uveitis Section, Self-Assessment Committee (in charge of developing a
program that will test and assess knowledge deemed necessary for maintenance of
certification by the American Board of Ophthalmology)
2007-2012
Member, COMPASS Committee on Uveitis and Ocular Inflammatory Diseases
2008-2010
Member, Annual Meeting Program Committee - Retina/Vitreous
American Medical Association
1994-1998
Massachusetts Delegate to the Resident Physicians Section
1995-1996
Resident Representative to the Surgical Caucus Executive
Committee
1996-1998
Editorial Board of JAMA, the Journal of the American Medical Association
Association for Research in Vision and Ophthalmology
2003-2006
Professional Development and Educational Committee
Harvard University, Mather House
1995-1998
Tutor, Health Sciences Advisory Committee
International Ocular Inflammation Society
2011Member of the Executive Committee
Joseph Richey Hospice (Baltimore, Maryland)
2002Volunteering Attending Physician
Joseph Richey Hospice is the only hospice in the United States that
is staffed by physicians who donated their time gratis. As attending
physician, I helped to admit and examine patients, and work with the
staff to ensure that terminally-ill patients are provided with the best
31
comfort and dignity during their last days of life.
Maryland Society for Sight
2002Member of the Board of Directors
Massachusetts Eye and Ear Infirmary
1994-1998
Continuous Quality Improvement Committee
1997-1998
Fellowship Steering Committee
Massachusetts Medical Society
1994-1998
Member, Governing Council of the Resident Physicians Section
1995-1997
Editor-in-Chief, Residents’ Report
1995-1997
Secretary, Governing Council of the Resident Physicians Section
1995-1998
Editorial Board of Vital Signs, the Publication of the MMS
1996-1997
Member, Tax-Supported Medical Care Committee
1997-1998
Member, Board of Trustees
1997-1998
Member, Finance Committee
Vietnamese American Medical Association
1998-2001
Vice President of the Executive Committee
Co-Chair, Membership Committee
2001-2004
General Secretary of the Board of Directors
2001-
Chair, Professor Pham Bieu Tam Award Selection Committee
2004-2007
2005
President
Chair of the Planning Committee and Program Director
Annual Meeting, September 22-25, Falls Church, Virginia
Re-elected as President
Vice Chair of the Board of Directors
2007-2010
2010-2013
Vietnamese Medical Association of the Free World
2002-2005
General Secretary of the Executive Committee
2005-2008
President
EDITORIAL ACTIVITIES
Editorial Board
2008Journal of Ocular Inflammation and Infection
Scientific Peer Reviewer
2001American Journal of Ophthalmology
2001Archives of Ophthalmology
2002European Journal of Clinical Microbiology & Infectious Diseases
2002Experimental Eye Research
2001Investigative Ophthalmology and Visual Science
32
200120032003200120042002-
Ocular Immunology and Inflammation
Ophthalmic Epidemiology
Ophthalmic Lasers & Surgery
Ophthalmology
Pediatric Blood and Cancer
Vietnamese Medical Journal
ADVISORY COMMITTEES, REVIEW GROUPS, AND STUDY SECTION
Food and Drug Administration, Office of Orphan Products Development
2006
Grant Application Study Review Panel
2009
Grant Application Study Review Panel (June and December)
Juvenile Diabetes Research Foundation International
2006Medical Science Review Committee
PROFESSIONAL SOCIETIES
1987Sigma Xi Honors Scientific Research Society
1990Vietnamese American Medical Association
1990Association for Research in Vision and Ophthalmology
1993Massachusetts Medical Society
1993American Medical Association
1994American Academy of Ophthalmology
1998American Uveitis Society
2002Association for Patient-Oriented Research
2002International Ocular Inflammation Society
2003American Federation for Medical Research
2003American Society of Retina Specialists
2004Macula Society
2005Retina Society
CONFERENCE ORGANIZER
American Academy of Ophthalmology
2002-2003
Creator of the Subspecialty Day in Uveitis and Ocular Inflammatory
Diseases
2003
Program Director, the 2003 Inaugural Subspecialty Day in Uveitis
and Ocular Inflammatory Diseases
2005
Program Director, the 2005 Subspecialty Day in Uveitis and Ocular
Inflammatory Diseases
2006Instructor, AAO Course on “Current Concepts in the Management of
AMD for the Comprehensive Ophthalmologists”
2008
Program Director, the 2008 Subspecialty Day in Uveitis and Ocular
Inflammatory Diseases
2010
Program Director, the 2010 Subspecialty Day in Uveitis and Ocular
Inflammatory Diseases
2012
Program Director, the 2012 Subspecialty Day in Uveitis and Ocular
33
Inflammatory Diseases
Association for Research in Vision and Ophthalmology
2003
Organizer and Moderator, Special Interest Group (SIG)
Ocular Imaging of Macular Diseases
2004
Organizer and Moderator, Special Interest Group (SIG)
Advances in Ocular Imaging of Macular Diseases
2005
Organizer and Moderator, Special Interest Group (SIG)
Blockade of VEGF: Lessons from Early Clinical Experiences
2006
Organizer and Moderator, Special Interest Group (SIG)
Novel Treatments and Assessments of Ocular Neovascularization
and Macular Edema: Lessons from Early Clinical Experiences
2007
Organizer and Moderator, Special Interest Group (SIG)
New Treatments and Assessments of Choroidal Neovascularization
and Macular Edema
2008
Organizer and Moderator, Special Interest Group (SIG)
New Approaches for Management of Retinal Vascular Diseases
2009
Organizer and Moderator, Special Interest Group (SIG)
New Approaches for Diagnosis and Management of Retinal
Vascular Diseases and Uveitis
2011
Organizer and Moderator, Special Interest Group (SIG)
Synthesizing the Latest data from DME and AMD Clinical Trials:
What Are the Implications and New Questions?
2012
Organizer and Moderator, Special Interest Group (SIG)
Synthesizing the Latest Data from DME, Neovascular AMD, and
RVO Clinical Trials: Significance and Implications
Foster Ocular Immunology Society
1998Chair of the Organizing and Scientific Committees
FOIS Annual Scientific Meeting
2004-
Executive Secretary
International Ocular Inflammation Society
2007
Meeting of the International Ocular Inflammation Society
Paris, France, September 16-20, 2007
Organizer of Three Symposia on the Role of Inflammation in AMD,
Glaucoma, Retinal Degeneration, and Diabetic Retinopathy
2009
Meeting of the International Ocular Inflammation Society
Prague, the Czech Republic, May 29 – June 2, 2009
Program Organizer and Moderator
2011
Meeting of the International Ocular Inflammation Society
Goa, India, November 12-16, 2011
34
Chair of the Scientific Committee
Johns Hopkins University School of Medicine
2008-2013
Course Co-Director
Annual Course, Updates on Age-Related Macular Degeneration
2010
Course Co-Director
Macula 2010 in conjunction with the 2010 Atlantic Coast Retina
Conference
2010
Course Director
Current Concepts in the Management of Diabetic Macular Edema
and Retinal Vein Occlusion
in Conjunction with the 2010 Annual ARVO Convention
2010
Course Director
Current Concepts in the Management of Diabetic Macular Edema
Uveitic Macular Edema, and Retinal Vein Occlusion
in Conjunction with the 2010 American Academy
of Ophthalmology Meeting
2011
Course Director
Macular Edema: Examining the Evidence
http://www.jhasio.com
2013
Course Co-Director
Macula 2013 in conjunction with the 2013 Atlantic Coast Retina
Conference
CONSULTANTSHIPS AND SCIENTIFIC ADVISORY BOARDS
2005Bausch and Lomb, Inc.
Member of the Uveitis and Retina Scientific Advisory Board
2006-
Santen, Inc.
Member of the Retina and Uveitis Scientific Advisory Board
2007-
Regeneron, Inc. (arrangements made through the Johns Hopkins
Institutional Consultancy Agreement)
Member of the Retina Scientific Advisory Board
Member of the Steering Committee of the VIEW 1 Study
2008-2009
Sirion Therapeutics, Inc.
Member of the Uveitis Scientific Advisory Board
35
2008-
Genentech, Inc. (arrangements made through the Johns Hopkins
Institutional Consultancy Agreement)
Chair of the Diabetic Macular Edema Steering Committee
Member of the LUCENTIS® Faculty
2008-
Pfizer, Inc. (arrangements made through the Johns Hopkins
Institutional Consultancy Agreement)
Member of the Retina Scientific Advisory Board
2009-
Acucela, Inc. (arrangements made through the Johns Hopkins
Institutional Consultancy Agreement)
Member of the Retina Scientific Advisory Board
2010-
Glaxo Smith Kline, Inc. (arrangements made through the Johns
Hopkins Institutional Consultancy Agreement)
Member of the Retina and Uveitis Scientific Advisory Boards
COMMUNITY AND ALUMNI SERVICES
1985-1989
Volunteer in the Emergency Ward, Yale-New Haven Hospital
1985-1989
Tutor in Chemistry for Students from New Haven public schools
1986-1989
Publisher and Chairman, Yale Scientific Publication, Inc.
1988-1989
Freshman Counselor, appointed by Yale College’s Dean Office
1989-1993
Member, Schools Committee, which Interviews Applicants to Yale
College, Yale Club of Philadelphia
1989-1990
Editor-in-Chief, 1990 Penn Med Guide to the First Year
1989Class Agent, Yale Alumni Fund
1990
Event Director and Chairman of the Finance Committee, Penn Med
Special Olympics Adult Tournament
1990-1992
Volunteer, Recording for the Blind, Inc., Philadelphia Chapter
1990-1993
Member, Dean’s Evaluations Committee, which evaluates members
of the faculty in the School of Medicine for promotion
1990-1993
Member, Penn Medical School Admission Interview Panel
1991-1993
Vice President, Exeter Association of Philadelphia
1992-1993
Editor-in-Chief, 1993 Scope, the Yearbook of Penn Medical School
1992-1993
President and Founding Member, Penn Med Asian American
Society
1993President, Penn Medical School, Class of 1993 (elected at
graduation)
1994-1997
Member, Lions Club, Boston-Brighton Chapter
1994-2001
Exeter Association of Boston
1994-2001
Member, Schools Committee, which interviews applicants to Yale
College, Yale Club of Boston
2001Member, Schools Committee, which interviews applicants to Yale
College, Yale Club of Maryland
36
2001200220032004-
Consultant for Ophthalmology, Voice of America (VOA), Southeast
Asian/Vietnamese Division
Lector, Cathedral of Mary Our Queen (Baltimore, Maryland)
Volunteer Attending Physician, Joseph Richey Hospice (Baltimore, Maryland)
President, Association of Yale Alumni of Maryland
RECOGNITION
HONORS AND AWARDS
1983-1985
Helen and Paul M. Wilkinson Memorial Academic Scholarship
1984
Tencher Prize for Best Effort in Studying the English Language
1985
Johns Parker Compton Memorial Award for High Scholarship and
Leadership
1985
Phillips Exeter Academy Science Department Award for Future
Scientist
1985
United States Presidential Academic Award
1985
Secondary School Diploma Summa Cum Laude, Highest Honors
1985-1989
Walter A. Marting Memorial Academic Scholarship
1987
Sigma Xi Scientific Society Summer Research Fellowship
1988
National Science Foundation Summer Research Fellowship
1988
Paul K. Richter Summer Fellowship for Independent Study
1989
Magna Cum Laude, Yale Chapter (Honors Combined
Bachelor’s/Master’s Program)
1989-1993
University of Pennsylvania Medical Scholar
1990
National Institutes of Health Medical Summer Research Fellowship
1989-1991
Walter Lewis Croll Academic Scholarship
1991-1992
John R. Lavine Scholarship for High Academic Achievements
1993
Sandoz Award for Outstanding Community Services and Academic
Achievements
1995
American Medical Association – Glaxo Achievement Award
Recognizing Tomorrow’s Leaders Today
1996
American Medical Association – Glaxo Wellcome Leadership Award
1998
Massachusetts Eye and Ear Infirmary Fellow of the Year Award
1998
Heed Ophthalmic Foundation Fellowship
1998
American Ophthalmological Society – Herman Knapp Fellowship
1999
National Institutes of Health – National Research Service Award
2001
Charles L. Schepens, M.D. Award for Excellence in Retina Research
2001-2006
Career Development Award (K23), National Eye Institute, National
Institutes of Health
2002-2004
National Institutes of Health Loan Repayment Award
2003
American Federation for Medical Research Glaxo Smith Kline Scholar
2003
Foundation Fighting Blindness Research Award
2004-2006
National Institutes of Health Loan Repayment Award
2004
Juvenile Diabetes Research Foundation Innovative Award
2005
T. Rowe Price Fellowship for Epidemiologic Study
2006
American Academy of Ophthalmology Achievement Award
37
2007
2007
2008-2011
2008
2009
2009
20102012
2012
2012
American Society of Retina Specialists Honor Award
American Academy of Ophthalmology Annual Meeting Best Abstract Award
National Institutes of Health/National Eye Institute RO1 Award
American Society of Retina Specialist Senior Honor Award
Research to Prevent Blindness Foundation Physician Scientist Award
Coulter Foundation Innovative Award
National Institutes of Health/National Eye Institute R24 Award
Association for Research in Vision and Ophthalmology Carl Camras
Translational Research Award
Club Jules Gonin Travel Grant Research Award
American Academy of Ophthalmology Senior Achievement Award
INVITED LECTURES
1.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals,
Current Concepts in Ophthalmology, Baltimore, Maryland, December 1998.
“Scleral Patch Graft in the Management of Scleritis”
2.
University of the Philippines, Philippines General Hospital, Manila, July 1999.
Visiting Lecturer
“Ocular Manifestations of AIDS”
3.
The Third International Congress of the Vietnamese Medical Association of the
Free World, Paris, France, August 2000.
“Ocular Manifestations of Systemic Immunologic Diseases”
4.
Annual Convention of the Vietnamese Medical Association of the USA, East
Meadowlands, New Jersey, August 2001.
“Preserving Vision through Advances in Technology: Where Have We Been …
Where Are We Going?”
5.
Annual Updates on What’s New in Diabetic Retinopathy and Venous Occlusive
Disease, The Wilmer Ophthalmological Institute, Johns Hopkins University,
Baltimore, Maryland, October 2001.
“Advances in the Treatment of Diabetic Macular Edema: Role of Oxygenation.”
6.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals,
Current Concepts in Ophthalmology, Baltimore, Maryland, December 2001.
“Supplemental Inspired Oxygen for Hypoxia-Mediated Retinal Diseases: A Pilot
Study.”
7.
2002 Annual Diabetes Conference, Johns Hopkins Bayview Medical Center,
Baltimore, Maryland, April 2002.
38
“Diabetic Eye Diseases and the Role of Nutritional Control.”
8.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals,
Ophthalmology for the Medical Practitioner, Baltimore, Maryland, October 2002.
“Diabetes Eye Diseases.”
9.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals,
Current Concepts in Ophthalmology, Baltimore, Maryland, December 2002.
“Current Concepts in the Diagnosis and Management of Retinal Vasculitis.”
10.
Division of Renal Medicine, Johns Hopkins Bayview Medical Center, Baltimore,
Maryland, December 2002.
“Diabetic Retinopathy: Diagnosis and Management.”
11.
Yale Eye Center, Yale University School of Medicine, New Haven, Connecticut,
May 15, 2003.
Visiting Professor and Ophthalmology Grand Round Speaker
“Management of Retinal Vasculitis.”
12.
Vietnamese American Medical Association 2003 Annual Convention
Orlando, Florida, July 25-27, 2003
“Diabetic Retinopathy: Current Concepts for the Non-Ophthalmologists.”
13.
Maryland Society of Eye Physicians and Surgeons 2003 Annual Meeting
Columbia, Maryland, October 17, 2003
“New Clinical Trials for Neovascular Age-Related Macular Degeneration.”
14.
American Academy of Ophthalmology 2003 Annual Meeting
Inaugural Uveitis Subspecialty Day
Anaheim, California, November 15, 2003
“Retinal Vasculitis: Current Concepts in Diagnosis and Management.”
15.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals,
Current Concepts in Ophthalmology, Baltimore, Maryland, December 2003.
“Current Clinical Trials for Neovascular Age-Related Macular Degeneration.”
16.
State University of New York at Syracuse
The 54th Annual Post-Graduate Course in Ophthalmology
December 5-6, 2003
Visiting Professor and Course Faculty Member
17.
Updates in Ocular Imaging: Optical Coherence Tomography- The State of the Art
The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker
January 17, 2004
“Principles of Optical Coherence Tomography Relevant to Clinical Applications.”
39
18.
Second Update on Ocular Infectious Diseases
The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker
May 21-22, 2004
“Diagnostic Molecular Microbiology for Infectious Uveitis.”
19.
Second Update on Ocular Infectious Diseases
The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker
May 21-22, 2004
“Current Perspectives in the Management of Ocular Toxoplasmosis.”
20.
Second Update on Ocular Infectious Diseases
The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker
May 21-22, 2004
“Chronic, Delayed-Onset Endophthalmitis.”
21.
University of California at San Francisco
Department of Medicine
May 26, 2004
Visiting Professor and Renal Grand Round Speaker
“Ocular Manifestations of Renal Diseases”
22.
Age-Related Macular Degeneration in 2004: From Prevention to Treatment
and Bench to Bedside
The Wilmer Ophthalmological Institute at Johns Hopkins – Invited Speaker
June 4-5, 2004
“The Potential Role of OCT in the Management of Macular Degeneration”
23.
Immunology and Inflammatory Diseases
30th Annual Kevin Hill Seminar in Ophthalmology – Visiting Professor
Colby College, Waterville, Maine
July 19-22, 2004
a. “The Eye as a Target for Inflammation”
b. “Posterior Inflammation: Vitritis, Intermediate Uveitis, and Retinal Vasculitis”
c. “Infectious Diseases of the Posterior Segments”
24.
American Academy of Ophthalmology Annual Meeting
New Orleans, Louisiana
October 22-26, 2004
Chair: Symposium on New Therapies for Macular Degeneration
25.
American Academy of Ophthalmology Annual Meeting
New Orleans, Louisiana
October 22-26, 2004
Paper Discussant: “Chorioretinal Manifestations of West Nile Virus Infection”
26.
American Academy of Ophthalmology Annual Meeting
40
New Orleans, Louisiana
October 22-26, 2004
Symposium on An Evidence-Based Medicine Review of the Literature on the Matter of Therapy
for Uveitis
Invited Speaker: “Evidence-Based Management of Adamantiades-Behçet’s Disease”
27.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals
Current Concepts in Ophthalmology, Baltimore, Maryland, December 2-4, 2004.
“Fluocinolone Acetonide Intravitreal Implant in the Management of Posterior
Uveitis: The One-Year Results of a Randomized Control Trial.”
28.
Bascom Palmer Eye Institute, University of Miami School of Medicine
Miami, Florida – Visiting Professor
February 4-5, 2005
Uveitis for the Other Sub-Specialist
a. “Is Retinal Vasculitis a Uveitis?”
b. “Scleritis: Patch Graft and Biopsy”
29.
Pan-American Congress of Ophthalmology, Pan-American Association of Ophthalmology
Santiago, Chile – Invited Speaker
March 18-21, 2005
a. “Novel Anti-VEGF Pharmacology for Neovascular AMD”
b. “New Therapies for AMD: Where Are We Going in 2005 and Beyond?”
c. “New Anti-angiogenic Agents for Choroidal Neovascularization Secondary to Uveitis”
d. “How to Approach and Diagnose a Patient with Uveitis?”
30.
Midwest Ocular Angiography Conference
Whistler, British Columbia, Canada
August 3-6, 2005
Presenter: “Cases of Masquerading Uveitis Syndrome”
31.
L.V. Prasad Eye Institute, Hyderabad, India
October 5, 2005
Visiting Professor
“Novel Pharmacologic Therapeutic Approaches for Neovascular Age-Related
Macular Degeneration”
32.
The 2005 Uveitis Society of India Annual Meeting
Jalna, India
October 7-9, 2005
Guest of Honor
“The Role of Sustained-Release Devices in the Management of Uveitis”
33.
The Wilmer Ophthalmological Institute, Johns Hopkins University and Hospitals
Current Concepts in Ophthalmology, Baltimore, Maryland, December 1-3, 2005.
“Fluocinolone Acetonide Intravitreal Implant in the Management of Posterior
41
Uveitis: The Two-Year Results of a Randomized Control Trial.”
34.
World Congress of Ophthalmology
Sao Paulo, Brazil, February 19-23, 2006
Invited Faculty
Symposia on “Novel Therapy for Ocular Neovascularization” and on
“Controversies in the Management on Ocular Inflammatory Diseases”
35.
The 2006 International Society of Ocular Pharmacology and Therapeutics
Berlin, Germany, March 29-April 1, 2006
Invited Speaker and Moderator
“Novel Therapy in the Management of Neovascular Age-Related Degeneration.”
“Management of Panuveitis.”
36.
New England Eye Center, Tufts University
2006 Innovations in AMD Therapy: A Revolution in Evolution
Boston, Massachusetts, April 7-8, 2006
Invited Faculty
“Novel Therapeutic Options for Ocular Neovascularization and Diabetic
Retinopathy.”
37.
Segundo Congreso de la Sociedad Panamericana de Retina y Vitreo
Cartagena de Indias, Colombia, May 17-20, 2006
Invited Faculty and Special Guest
“Management of Neovascular AMD in 2006 and Beyond: What is the Future?”
38.
The 2006 Retinal Physician Symposium
Nassau, the Bahamas, May 31-June 1, 2006
Invited Faculty
“Ranibizumab for Edema of the Macula in Diabetes: Results of the READ 1 Study”
“Current Concepts in the Diagnosis and Management of Ocular Toxoplasmosis”
“Immunomodulatory Therapy for Uveitis and Ocular Inflammatory Diseases”
39.
The Second French-American Ophthalmological Symposium
New York, New York, June 2-3, 2006
Invited Faculty
“Where Are We Going in the Management of Ocular Neovascular Diseases?”
40.
Albany Medical College Annual Ophthalmology Update
Albany, New York, June 15-16, 2006
Visiting Professor
“Current Concepts in the Management of Uveitis and Ocular Inflammatory Diseases”
41.
The 90th Annual Pacific Coast Oto-Ophthalmological Society Meeting
Cabo San Lucas, Mexico, June 23-27, 2006
Special Guest Speaker
42
“Local and Systemic Therapy for Choroidal Neovascularization”
“Ocular Manifestations of Systemic Autoimmune Diseases”
42.
The 2006 Annual Meeting of the American Association of Diabetes Educators
Los Angles, California, August 8-9, 2006
Invited Faculty
“Molecular Pathways of Diabetic Retinopathy: Where Are We Going with Therapy
in the 21st Century”
43.
2006 Macula in Paris Conference
Paris, France, September 5-6, 2006
Invited Faculty
“Coming to the Clinics: Potential New Therapy for Neovascular AMD”
44.
2006 Meeting of the Pan-Hellenic Conference on Ocular Inflammation and
Infections
Island of Crete, Greece, October 27-29, 2006
Guest of Honor and Invited Speaker
“Retinal Vasculitis: Pathophysiology and Management”
“Management of Uveitis Choroidal Neovascularization”
45.
2006 Annual Meeting of the Philippine Academy of Ophthalmology
Manila, the Philippines, November 24-28, 2006
Guest of Honor and Invited Speakers
“Current Concepts in the Management of Posterior Uveitis”
“Necrotizing Scleritis: Pathogenesis, Diagnosis, and Management”
46.
The 2006 Annual Meeting of the Uveitis Society of India
Madurai, India, December 2-3, 2006
Invited Speaker
“Current Concepts in the Use of Fluocinolone Acetonide Sustained-Release Device
in the Management of Posterior Uveitis”
“Challenges in Managing Complications of Posterior Uveitis”
47.
Macula 2007
Baltimore, Maryland, January 12, 2007
Invited Speaker
“Potential Role of VEGF Trap in the Management of Neovascular AMD”
48.
University of Louisville
Louisville, Kentucky, February 15-16, 2007
Visiting Professor
“Retinal Vasculitis: Challenges in Diagnosis and Management”
“Coming to the Clinics: Pharmacologic Agents in Clinical Trials for Retinal Diseases”
43
49.
Angiogenesis 2007
Bascom Palmer Eye Institute, University of Miami
Miami, Florida, February 23-24, 2007
Invited Speaker
“VEGF Trap for Diabetic Macular Edema and Neovascular AMD”
50.
The 50th Annual Postgraduate Symposium in Ophthalmology
William H. Havener Eye Institute
The Ohio State University
Columbus, Ohio, March 2-3, 2007
Visiting Professor and Invited Speaker
“Ocular Manifestations of Systemic Autoimmune Diseases”
“Managing Neovascular AMD in 2007 and Beyond”
51.
The Phoenix Ophthalmological Society Annual Meeting
Phoenix, Arizona, March 22, 2007
Guest of Honor and Invited Speaker
“Current Concepts in the Diagnosis and Management of Retinal Vasculitis”
52.
New England Eye Center, Tufts University
ARMD and Retinal Vascular Diseases 2007: Optimizing Treatments
Boston, Massachusetts, March 30-31, 2007
Invited Faculty
“Ranibizumab for Macular Edema secondary to Retinal Vein Occlusion”
53.
The 2007 Retinal Physician Symposium
Fort Meyers, Florida, April 11-14, 2007
Invited Faculty
“The Role of VEGF Inhibition in the Management of Diabetic Macular Edema”
“White Dot Syndromes: Current Concepts in Diagnosis ad Treatments”
54.
The First Annual Uveitis Symposium – Posterior Uveitis: Diagnosis and Treatment
University of Illinois Eye and Ear Infirmary, Chicago, Illinois, April 21, 2007
Invited Speaker
“Therapy for Uveitic Subretinal Neovascularization”
“Diagnostic and Therapeutic Vitrectomy for Uveitis”
55.
IX Congreso Internacional Clinica de Oftalmologia de Cali
Cali, Colombia, May 24 – 26, 2007
Visiting Professor and Invited Speaker
“The Role of HbA1C in the Management of Diabetic Eye Diseases”
”Updates in the Medical and Surgical Therapy for Uveitis”
56.
XXVIII Congreso PanAmericana de Oftalmologia
Cancun, Mexico, May 30 – June 4, 2007
Invited Speaker
44
“VEGF Trap in the Management of Neovascular AMD”
“Retinal Biopsy in the Management of Ocular Inflammatory Diseases”
57.
2007 Annual Convention of the Juvenile Diabetes Research Foundation
Global Diabetes Research Forum
Saint Louis, Missouri, June 1, 2007
Featured Invited Speaker
“Ranibizumab for Edema of the mAcula in Diabetes: A Phase 2 Study – the READ
2 Study. What is Ahead for Patients with Diabetic Macular Edema?”
58.
The Third French-American Ophthalmological Symposium
Boston, Massachusetts, June 15-16, 2007
Invited Faculty
“New Treatments for Neovascular AMD: What Are Coming to the Clinic?”
“New Treatments for Uveitis and Ocular Inflammatory Diseases”
59.
First Annual Geneva Uveitis Society Conference
Geneva, Switzerland, September 12-13, 2007
Invited Faculty
“Current Concepts in the Management of Retinal Vasculitis”
60.
2007 Retina Subspecialty Day at the Annual Meeting of the American Academy of
Ophthalmology
New Orleans, Louisiana, November 9-13, 2007
Invited Speaker
“VEGF Trap for AMD”
61.
2008 Les Journees Ophtalmologiques de L’Universite Laval (JOUL)
Quebec, Canada, February 7-8, 2008
The Jean Lacerte Lecturer
“What Are Coming to the Clinics for the Management of Neovascular AMD?”
“Ocular Manifestations of Systemic Autoimmune Diseases”
62.
2008 Macula: Advances in Diagnosis and Therapy (MAT)
Torino, Italy, February 9-10, 2008
Invited Speaker and Session Chair
“Updates on VEGF Trap for Neovascular AMD”
63.
2008 Angiogenesis, Exudation, and Degeneration Meeting
Bascom Palmer Eye Institute, University of Miami
Miami, Florida, February 22-23, 2008
Invited Speaker
“Updates on VEGF Trap for DME and Neovascular AMD”
45
64.
The 7th International Symposium on Ocular Pharmacology and Therapeutics
Budapest, Hungary, February 28 – March 2, 2008
Invited Speaker and Session Chair
65.
The 33rd Meeting of the Brazilian Retina Society
Bahia, Brazil, April 3-5, 2008
Invited Speaker and Program Discussant
66.
2008 Jornadas Nacionales de Oftalmologia
Consejo Argentino de Oftalmologia
III Symposio Internacional de la Sociedad Argentina de Retina y Vitreo y Uveitis
Annual Meeting of the Argentinian Academy of Ophthalmology
The 3rd International Symposium of the Argentinian Society of Retina and Vitreous, and Uveitis
Buenos Aires, Argentina, May 23-25, 2008
Invited Speaker and Session Chair
67.
The 2008 Retinal Physician Symposium
Naples, Florida, May 28-31, 2008
Invited Faculty and Program Discussant
68.
The 2008 University of Buffalo Annual Ophthalmology Symposium
Buffalo, New York, June 6-7, 2008
Visiting Professor
69.
XXVII Reunion Annual de Retina
The 27th Meeting of the Mexican Retina Society
Acapulco, Mexico, June 11-14, 2008
Invited Speaker and Session Chair
70.
2008 Meeting of the Korean Retina Society
Yonsei University School of Medicine
Seoul, Korea, June 25-26, 2008
Guest of Honor and Visiting Professor
71.
2008 World Congress of Ophthalmology
Hong Kong, China, June 29 – July 2, 2008
Invited Speaker and Program Chair for Symposia in Retina and Uveitis
72.
34th Annual Kevin Hill Seminar in Ophthalmology – Retina Update
Colby College
Waterville, Maine, July 13-17, 2008
Invited Faculty
73.
The 26th Visiting Retina Professor
The Retina Center at Pali Momi
University of Hawaii School of Medicine
46
Honolulu, Hawaii
August 30, 2008
74.
The 2008 Amsler Club Annual Meeting
Newcastle, the United Kingdom
October 31 – November 1, 2008
Honored Guest and Invited Speaker
75.
The 20th Anniversary Meeting of the Vietnamese Association of Physicians,
Dentists, and Pharmacists of Florida
Orlando, Florida
November 21 – 23, 2008
Honored Guest and Invited Speaker
76.
The 10th Annual Research Day
Federal University of São Paulo
Department of Ophthalmology, Vision Institute
São Paulo, Brazil
December 11-13, 2008
Visiting Professor
77.
The 2009 Macula of Paris Meeting
Paris, France
January 23-25, 2009
Invited Faculty
78.
The 2009 Florida Retina Symposium
Sarasota, Florida
March 13 – 14, 2009
Invited Faculty
79.
The 2009 Retina Physician Symposium
Nassau, the Bahamas
March 25 – 28, 2009
Invited Faculty
80.
2009 Yale Retina Symposium
New York, New York
April 3 – 4, 2009
Invited Faculty
81.
2009 Annual Meeting of the Maryland Society of Eye Physicians and Surgeons
Baltimore, Maryland
May 8, 2009
Invited Faculty
47
82.
2009 International Ocular Inflammation Society
Prague, the Czech Republic
May 29 – June 2, 2009
Invited Faculty, Program Organizer and Chairman, and Moderator
83.
2009 French American Ophthalmology Symposium
New York, New York
June 5 – 6, 2009
Program Chairman and Invited Faculty
84.
George Washington University School of Medicine
Department of Ophthalmology
Washington, District of Columbia
June 12, 2009
Visiting Professor and Honored Guest Speaker
85.
Medical University of Vienna
Department of Ophthalmology
Vienna, Austria
November 13, 2009
Visiting Professor
86.
2009 EuRetina Winter Meeting and Advanced Retinal Therapy (ART) Meeting
Vienna, Austria
November 14-15, 2009
Invited Faculty
87.
The 2010 Macula of Paris Meeting
Paris, France
January 14 – 16, 2010
Invited Faculty
88.
Macula 2010
Baltimore, Maryland
January 22-23, 2010
Course Co-Director and Invited Faculty
89.
El XLVII Curso de Actualizacion en Oftalmologia: Las Enfermedades
Inflamatorias Oculares/Uveitis
Mexico City, Mexico
February 2-4, 2010
Invited Faculty
90.
Angiogenesis 2010
Miami, Florida
48
February 19-20, 2010
Invited Faculty
91.
Columbia University, Edward Harkness Eye Institute
New York, NY
April 1, 2010
Visiting Professor and Grand Round Lecturer
92.
Albert Einstein College of Medicine, Montefiore Medical Center
Bronx, New York
April 2, 2010
Visiting Professor and Grand Round Lecturer
93.
2010 Brazilian Retina Society
São Paulo, Brazil
April 19-22, 2010
Guest of Honor and Invited Speaker
94.
Kansas University, Kansas EyeCon 2010
Kansas City, Missouri
May 7, 2010
Visiting Professor and Conference Lecturer
95.
2010 World Congress of Ophthalmology
Berlin, Germany
June 4-9, 2010
Symposium Organizer, Session Chair, and Invited Faculty
96.
2010 Retina Subspecialty Day at the Annual Meeting of the American Academy of
Ophthalmology
Chicago, Illinois, October 15-19, 2010
Invited Speaker
97.
XIX Reunião de Oftalmologia
Lisbon, Portugal
November 5-6, 2010
Guest of Honor and Invited Speaker
98.
The 2011 Macula of Paris Meeting
Paris, France
January 14-16, 2011
Invited Faculty
99.
The 2011 Atlantic Coast Retina Club and Macula 2011
49
Philadelphia, Pennsylvania
January 27-29, 2011
Invited Faculty
100.
The Bascom Palmer Eye Institute Angiogenesis 2011
Miami, Florida
February 11-12, 2011
Invited Faculty
101.
The University of Toronto School of Medicine, Department of Ophthalmology
Toronto, Canada
March 31 – April 1, 2011
Visiting Professor and Grand Round Lecturer
102.
The University of Nebraska School of Medicine, Department of Ophthalmology
Omaha, Nebraska
April 13 – April 14, 2011
Visiting Professor and Grand Round Lecturer
103.
The 5th French American Ophthalmology Symposium
Montreal, Canada
June 15 – 19, 2011
Co-Chair, Scientific Program Committee and Invited Speaker
104.
The 96th Annual Meeting of the Oxford Ophthalmological Congress
Oxford, England
July 3 – 6, 2011
Invited Faculty and Guest of Honor
105.
2011 Annual Southeast Eye Congress
Destin, Florida
July 21 – 24, 2011
Invited Faculty
106.
Asia Eye Institute 10th Anniversary Scientific Congress
Manila, Philippines
September 24 – 26, 2011
Invited Faculty and Guest of Honor
107.
The 2011 Congress of the International Ocular Inflammation Society
Goa, India
November 11 – 16, 2011
Chair of the Scientific Program Committee
108.
Macula 2012 Congress
New York, New York
50
January 19-21, 2012
Invited Faculty
109.
IV Jornadas Oftalmologics
Caracas, Venezuela
January 26 – 29, 2012
Invited Faculty and Guest of Honor
110.
Cleveland Ophthalmological Society
Cleveland, Ohio
February 14, 2012
Featured Faculty and Guest of Honor
111.
Case Western University Department of Ophthalmology
Cleveland, Ohio
February 15, 2012
Visiting Professor and Grand Rounds Lecturer
112.
Ohio State University William Havener Eye Institute 55th Annual Symposium
Columbus, Ohio
March 2-3, 2012
Visiting Professor and William H. Havener Memorial Lecturer
113.
The 7th Hippocratic Meeting for Retina, Macula, and Vitreous
Thessaloniki, Greece
March 16-17, 2012
Invited Faculty and Guest of Honor
114.
The 2012 Asia Pacific Academy of Ophthalmology
Busan, Korea
April 12-16, 2012
Program Chairman, Moderator, and Invited Faculty
115.
2012 Societe Francaise d’Ophtalmologie Annual Congress
SFO – Wilmer Eye Institute Joint Symposium
Paris, France
April 27-30, 2012
Invited Faculty
116.
2013 Glaucoma 2.0: Bench to Bedside
Bascom Palmer Eye Institute
Miami, Florida
January 26, 2013
Invited Faculty
51
117.
The Bascom Palmer Eye Institute Angiogenesis 2013
Miami, Florida
February 9, 2013
Invited Faculty
Updated: 040613